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ABSTRACT  
 
The eukaryotic green alga, Chlamydomonas reinhardtii, is a unique expression 
platform that can efficiently express complex therapeutic proteins. However, 
demonstrating that therapeutic molecules can be produced in quantifiable levels is 
essential to establish the potential of the C. reinhardtii expression system. Thus, the 
objective of the first part of investigation (Chapter II) was to determine the process 
conditions that could maximize C. reinhardtii biomass accumulation and induced-
production of the two recombinant proteins, a single chain fragment antibody molecule 
(αCD22 scFv) and malaria vaccine antigen (Pfs25), produced in the chloroplast of C. 
reinhardtii. To achieve a higher production of recombinant proteins, cultivation 
variables of C. reinhardtii, such as mixing, light-induction time and intensity, nutrient 
depletion and culture age, were investigated and optimized. The optimal light-induction 
time was 24 h at a light intensity of 300 μmol m−2 s−1. Replacement of the culture media 
in the late exponential growth with fresh media was beneficial to the accumulation of 
recombinant proteins. Optimization led to increases in the accumulation of recombinant 
proteins by six-fold and the recombinant protein fraction in the extracted soluble protein 
by two-fold. 
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The pharmaceutical applications of these molecules are limited because variables 
affecting downstream processes are not well understood; consequently the potential 
value of the product is being masked for the viability with regards to economics. Thus, 
the objective of second part of the investigation (Chapter III) was to examine extraction 
and pretreatment methods to maximize the recovery of αCD22 scFv from C. reinhardtii 
extract, while minimizing the amount of impurities recovered. The optimal extraction 
was in 50 mM Tris buffer with 400 mM NaCl and 0.5% Tween at pH 8. Different 
pretreatment methods, i.e., ammonium sulfate precipitation, acidic precipitation and 
polymer (chitosan) precipitation were evaluated based on their ability to reduce 
impurities and  maximize recovery of αCD22 scFv from algal extract. All the 
pretreatments tested on cell-free extracts were effective in reducing the amount of 
impurities and turbidity, with no loss in yield of αCD22 scFv. However, in case of cell 
lysates, a significant loss (~30%) of αCD22 scFv was observed with all three 
pretreatments. Chitosan precipitation, in particular is a promising method, which 
significantly reduced all the impurities, including DNA and turbidity.  
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CHAPTER I 
INTRODUCTION AND LITERATURE REVIEW 
 
1.1. Background 
 
Protein therapeutics are rapidly growing market with products in most branches 
of medicine. These protein therapeutics include vaccines, immunotoxins, single chain 
antibody fragments, cytokines which have advanced to the cusp of clinical success [1]. 
They are currently produced by either mammalian cell culture which is expensive 
because of complex nutritional and growth requirements and specialized bioreactor 
design, or in E. coli which is inefficient in expressing properly folded, complex proteins 
as soluble molecules. Other alternative systems like yeast, plants and insect cells also 
have their share of limitations, which restrict their use commercially [2-4] 
With simple growth requirements, rapid growth, scalable production, eukaryotic 
alga, Chlamydomonas reinhardtii offers an attractive alternative for production of 
therapeutic recombinant proteins. Our collaborators have already demonstrated that C. 
reinhardtii is able to produce complex, unique large dimeric functional immunotoxin, 
single chain antibody fragment, malaria vaccine proteins that cannot be efficiently 
expressed in and purified from other heterologous systems [2, 5, 6]. However, these 
unique therapeutic molecules have high-impact potential provided that C. reinhardtii is 
established as a viable production system from which the recombinant proteins can be 
produced and purified at a competitive cost on a commercial scale.  
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The thesis addresses broadly two different bioprocess technology challenges: (i) 
increasing production of recombinant proteins αCD22 scFv and Pfs25 in C. reinhardtii 
chloroplast by optimizing cultivation and light induction variables (upstream processing) 
(Chapter II) and (ii) maximizing recovery of αCD22 scFv in algae extract (Chapter III). 
The expression cassette designed by our collaborator to replace endogenous psbA gene 
with the transgenes regulated by endogenous psbA promoter provides unique 
opportunity for decoupling biomass production and protein accumulation. The overall 
goal of the project was to identify and address the various obstacles in establishing 
microalgae as a platform for therapeutic recombinant proteins. 
 
1.2. Literature Review 
 
1.2.1. Use of microalgae as a therapeutic production platform 
Around 130 protein therapeutics have been approved by US Food and Drug 
Administration (FDA) in a span of over 25 years, which has led to successful treatment 
of diseases like diabetes, hepatitis, etc.  These therapeutics include cytokines, vaccines, 
antibody based drugs, enzymes, etc. These therapeutics are produced in a number of 
heterologous protein expression systems. These systems have their distinct pros and cons 
with respect to yield of the protein, operation cost and ease of manipulation [7].  
Cultured transgenic mammalian cells are currently the most popular expression 
system for production of complex mammalian proteins and monoclonal antibodies 
(mAbs). However, it has its share of shortcomings like complex nutritional and growth 
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requirements, need for specialized bioreactors, expensive operation, and, with exception 
of monoclonal antibodies, low expression titers [8]. While bacterial systems like E. coli 
are efficient in producing large quantities of recombinant protein economically, they 
have limitations with respect to production of properly folded complex proteins as 
soluble molecules with properly formed disulfide bonds [9]. Yeast expression system is 
also being evaluated but there is variability in their N-linked and O-linked glycosylation 
machinery compared to the machinery found in mammalian cells which frequently leads 
to proteins that are not suitable for use as human therapeutics [10]. Transgenic plants 
like tobacco are also currently being investigated as a therapeutic production platform as 
they are free from human pathogens, and capable of post- translational modifications. 
However, the long development time for transgenic plants [11, 12] along with regulatory 
uncertainty [13] and purification challenges are potential disadvantages that are being 
addressed [14]. There have been advancement and improvement in developing these 
traditional expression systems. However, these systems are not ideal for expression and 
production of certain complex therapeutic proteins such as cytokines and eukaryotic 
toxins which require disulfide bond formation (limits use of E.coli cells) and are toxic to 
eukaryotic translational machinery(limits use of CHO cells) [15]. The development of 
algae as a platform for therapeutic protein production provides an opportunity to address 
the challenges faced by established expression systems. 
Surprisingly, there have been few reports on the generation of transgenic algae for 
the expression of recombinant proteins [4], even though green algae have served as a 
model organism for understanding everything from the mechanisms of light and nutrient 
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regulated gene expression to the assembly and function of the photosynthetic apparatus.  
Recent studies have demonstrated the potential of microalgae as a factory of 
recombinant protein production; i.e., 1) therapeutic proteins, which are difficult to 
produce and 2) industrial proteins as secreted high-value products during cultivation of 
microalgae [4, 6, 16]. Generally Recognized as Safe (GRAS) eukaryotic algae offer 
several advantages over other systems: (i) significant reduction in cost, (ii) length of 
time required to grow is relatively quick (doubling time 8-12 hours) [17, 18], (iii) it is 
easily grown in a full containment and is scalable, (iv) not susceptible to viral or prion 
contamination that can harm humans, as is always a concern with animal cell culture, (v) 
possess the chaperones and cellular machinery required to fold complex human proteins 
that bacteria and yeast may not be able to process properly, (vi) microalgae 
Chlamydomonas reinhardtii can be grown photosynthetically as well as non-
photosynthetically with acetate as carbon source, and (vii) unlike transgenic plants, 
uniform cellular population of algae can provide an opportunity for robust purification 
with easier scale up and minimized product losses. All three genomes (chloroplast, 
mitochondrial, and nuclear) can be transformed in Chlamydomonas, and each has 
distinct transcriptional, translational, and post-translational properties that make them 
distinct. Chloroplast offers some unique attributes, i.e. (i) correctly folds and assemble 
complex mammalian proteins due to presence of chaperons and ability to form disulfide 
bonds, (ii) in algae that grow non-photosynthetically, the chloroplast can provide a 
protected intracellular space that is non-essential to cell growth, (iii) tools to genetically 
manipulate the chloroplast and over-express proteins already exist, (iv) accumulation of 
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higher level of recombinant proteins in chloroplast, mainly because there are minimum 
gene silencing mechanisms in plastids, (v) chloroplasts can be transformed with multiple 
genes in a single event, due to the availability of multiple insertion sites, as well as an 
ability to process polycistronic transcripts, allowing an entire gene cassette to be 
regulated by a single promoter, and (vi)  chloroplast allows toxins that target the 
eukaryotic translational apparatus to be produced, where they are sequestered from the 
cytosol where they would otherwise be lethal to the host cell [2-5, 16, 19-21]. 
Eukaryotic green algae C. reinhardtii have been engineered to produce a wide 
range of recombinant proteins. Mayfield lab has demonstrated expression of ~40 
proteins in C. reinhardtii chloroplast, all remained soluble with very low amounts of the 
recombinant proteins associated with insoluble cell fractions [4, 22].   These include a 
dimeric immunotoxin (CD22-HCH23-ETA) for cancer treatment [6], cytokine (IL-
17D) with tumor suppressing properties, malaria vaccine (Pfs 25) [5], and human 
monoclonal antibody against anthrax protective antigen 83 (PA83)[22] etc. Surzycki et. 
al. [23] analyzed factors affecting protein expression in C. reinhardtii chloroplast and 
listed the following main factors: correct codon optimization, protein toxicity, proteinase 
activity and transformation–associated genotypic modification [23]. Biolistic 
transformation methods have been used to introduce foreign DNA into the C. reinhardtii 
chloroplast.  The DNA is inserted into specific sites in the chloroplast genome via 
homologous recombination and transformants are positively selected by using a 
kanamycin resistance gene that is delivered by the same plasmid bearing the 
recombinant gene of interest.  
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1.2.2. Single chain antibody fragment 
Single chain antibody fragments (scFvs) are highly relevant in the development of 
diagnostics and therapeutics and account for 35% of antibody fragments in clinical trials 
[24-26]. An scFv fragment consists of the smallest functional antigen-binding domain of 
an antibody (~30 kDa), in which the variable heavy (VH) and variable light (VL) chains 
are joined together by a flexible peptide linker [27] (Figure 1). The linker (3.5 nm in 
length) usually have hydrophilic residues with stretches of Gly and Ser for flexibility 
[28, 29]. In comparison to full-length mAbs, scFv fragments have several advantages 
such as (i) improved pharmacokinetic properties due to better tissue penetration and 
rapid blood clearance, (ii) low immunogenicity due to absence of Fc region. Thus, scFv 
fragments are beneficial in radiotherapy, diagnostic and therapeutic applications.  [30]. 
 
 
Figure 1. Schematic representation of full-length monoclonal antibodies (mAb) and 
single chain variable domain (Fv) fragments (scFv) fragments. 
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However, scFvs has several disadvantages too. For instance, its small size makes it 
unstable and prevents its accumulation at the target size, thus making it undesirable for 
therapeutic applications. This has been addressed by increasing their in vivo half-life and 
stability though various modifications, such as PEGylation. However, certain technical 
challenges need to be overcome to produce them cost-effectively in this format. 
Secondly, the lack of Fc-mediated cytotoxicity limits the therapeutic potential of scFvs. 
Thus, they are usually conjugated to drugs and toxins to be more effective in therapies 
[30]. 
 scFvs fragments have a broad range of applications. They can be genetically 
manipulated and engineered to yield multivalent and multifunctional multimers 
(diabodies, triabodies and tetrabodies) that have higher avidity and lower blood 
clearance, without compromising tissue penetration abilities [31]. Moreover, scFv 
fragments can be further engineered so that they are linked to different moieties, such as 
drugs, toxins, radionuclides, quantum dots or liposomes [24, 32]. Other application of 
scFv includes its use as molecular tools to perturb protein functions in vivo [33, 34], 
delivery agents of radionuclides in diagnostic imaging [35] and as potential therapeutics 
for diseases like cancer, HIV and neurodegenerative diseases [36-38]. 
One of the applications of scFv is to construct specific immunotoxin molecules 
[39]. Recently, Mayfield group at UC San Diego has demonstrated the ability of 
eukaryotic algae C. reinhardtii chloroplast to produce and accumulate a unique full 
length immunotoxin as cancer therapeutic. Immunotxin has been produced by 
genetically fusing the single chain (scFv) antibody that recognizes the CD22 antigen 
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from B-cells leukemia and lymphomas with eukaryotic toxin (a truncated variant of 
Pseudomonas aeruginosa exotoxin A ETA). They demonstrated the production of single 
chain (scFv) antibody fragment, monomeric and larger dimeric active immunotoxins 
from algae which are capable of binding specifically to B cells displaying the CD22 
molecule and causing them to undergo apoptosis [6]. 
 
1.2.3. Microalgae cultivation 
At present, the most common procedure for cultivation of algae is photoautotrophic 
growth in open ponds. Photoautotrophic growth of algae in large open outdoor ponds has 
been used since the 1950s for production of single-cell protein, health food, and b-
carotene [40, 41] and is one of the oldest industrial systems [42].  However, poor light 
penetration, costly and laborious harvesting, requirement of continuous and clean water 
supply and difficulty in mono cultivation of algae has restricted its use for production of 
pharmaceuticals and food ingredients. The numerous photobioreactors designed to 
overcome the disadvantage of the open pond system have been successful in achieving 
higher biomass productivity but its high cost in facility and operation and limiting light 
penetration on large scale leads to a lower economical viability than open pond [41]. 
Heterotrophic culture is a practical alternative for photoautotrophic culture. In 
heterotrophic cultures, organic carbons such as sugars and organic acids are used as 
carbon sources in the absence of light. Because the heterotrophic culture can be 
performed in conventional bioreactors, it is much easier to alter conditions to improve 
the yield of biomass and reduce the cost of microalgae biomass production [43]. The 
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heterotrophic growth of algae offers a promising alternative with fast algal growth, high 
production rate and convenient harvesting [44, 45].  Recently, heterotrophic microalgae 
culture has also been used on an industrial scale to produce biodiesel and 
polyunsaturated fatty acids. Under heterotrophic conditions, the growth rate, lipid 
content accumulation, ATP yield (mg of biomass generated/mg of ATP consumed), and 
N content are higher than under autotrophic conditions; however, the growth rate and 
amount of each of the products mentioned above are highly related to the algae species. 
Addition of oxygen under heterotrophic conditions is a key factor to maintain the growth 
rate and biomass production of high cell density cultures [41].  In mixotrophic growth, 
both respiratory and photosynthetic metabolism operates concurrently with assimilation 
of both CO2 and organic carbon. This type of cultivation provides all the benefit of 
heterotrophic cultivation plus the ability of synthesize photosynthetic metabolites [45]. 
Heterotrophic cultures have several limitations including contamination and 
competition with other microorganism; inhibition of growth by excess organic substrate; 
and inability to produce light-induced metabolites [45]. Nonetheless, there are many 
practical advantages of heterotrophic growth of microalgae and hence it is gaining 
increasing interest for producing a wide variety of metabolites at all scales, from bench 
experiments to industrial scale [41, 46, 47]. 
Glucose [47, 48], Glycerol [49] and acetate are some common carbon source used 
for heterotrophic cultures of microalgae. Acetate (carried by coenzyme A) is generally 
oxidized metabolically through two pathways: (a) the glyoxylate cycle to form malate in 
glyoxysomes (specialized plastids in the glyoxylatecycle) and (b) through the 
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tricarboxylic acid cycle (TCA) to citrate in the mitochondria, which provides carbon 
skeletons, energy as ATP, and energy for reduction (NADH) [41]. In C. reinhardtii 
growing on acetate, the oxidative pentose phosphate pathway is also active, providing 
reducing power as NADPH for cytosol [50]. Additionally, mitochondrial and 
chloroplastic electron transport chains are active in these cells and have a close 
interaction through the glycolytic pathway [51]. 
 
1.2.4. Light induction for recombinant protein expression 
It has been observed that codon optimization , promoter and regulatory mRNA 
untranslated region (UTR) choices are crucial factors in regulating transgene expression 
levels in C. reinhardtii chloroplast [52, 53]. Some of the first attempts to express 
recombinant proteins in the chloroplast of C. reinhardtii were under the control of 
promoters such as: rbcL, psbD and atpA [54-56]. But, the most successful promoter to 
date in algae is the psbA promoter in combination with the psbA UTRs [19, 23]. 
The Dl protein of photosystem II (PSIl) encoded by the psbA mRNA, is a reaction 
center protein that participates directly in photosynthetic charge separation and has been 
shown to be the most highly synthesized protein in illuminated photosynthetic cells [57]. 
In the C. reinhardtii strain studied, endogenous psbA gene coding for D1 protein, was 
replaced by the anti-CD22scFv (MT44) via direct homologous recombination of the 
psbA locus, by using a chloroplast expression cassette that contained anti-
CD22scFv/immunotoxin and kanamycin (kan) resistance coding region. Since 
recombinant protein expression is controlled by the psbA promoter, transgene expression 
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is light inducible [5, 6, 57]. Light distribution in microalgae cultures is highly 
heterogeneous due to absorption and scattering by cells [58]. 
Light regulates translation of psbA regulated proteins in algae C. reinhardtii by 
modulating the binding of activator proteins to the 5' untranslated region of psbA 
messengerRNA in vivo. This is achieved by mechanism involving redox potential of 
these proteins [59] and protein phosphorylation [57]. 
 
1.2.5. Extraction of recombinant protein from algae extract 
There are many types of cell disruption techniques depending on the type of cell. 
Most of the cells have certain characteristics which guide the selection of cell disruption 
technique to be used. For instance, animal cells like CHO cells can be broken easily 
compared to plant tissues which are more difficult to disrupt due to presence of 
cellulosic cell wall [60]. Physical disruption of high-water content biomass, such as 
Lemna, plant cell culture, and algae, can be accomplished by using high-shear mixers 
and/or high pressure homogenizers in the presence of buffer [61]. Various cell disruption 
techniques tested for algae include homogenizers, ultrasonic, french press [62]. Efficient 
cell disruption is crucial for maximum recovery of the target protein in the extract. A 
range of tissue to buffer ratio is used (1:1.5 to 1:10). Lower ratios are preferred as they 
reduce the process volume, but it should be carefully chosen so as to prevent the loss in 
the recovery of recombinant protein.  
Extraction of recombinant protein is often accompanied by impurities like DNA, 
chlorophyll and other pigments, host cell proteins, alkaloids, phenolics, polysaccharides, 
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and proteases. Extraction optimization is done to reduce/remove these impurities from 
the extract as these components can bind or degrade the recombinant protein affecting 
final product quality and yield or reduce purification efficiency due to resin or 
membrane fouling. Also, extraction optimization can protect the recombinant protein 
from degradation by proteolysis or phenol oxidation [61, 63-68].  
Depending on the characteristics of source biomass, target protein and cell 
disruption technique, different components are present in the extraction buffer. 
Generally phosphate buffers are used for basic pH extraction of recombinant proteins 
from green tissue, acetate buffer for acidic pH extraction, and Tris buffer for neutral pH 
[22, 69]. Detergents like Triton X-100, Tween are added for extraction of recombinant 
proteins from membrane associated proteins [64] and chloroplast expressed proteins [70, 
71]. Protein stabilizers such as: protease inhibitor, antioxidant, and metal chelating 
agents EDTA, are often added to the extraction buffers to prevent protein degradation. 
Extraction pH, temperature and extraction time are other factors which affect extraction 
efficiency and product quality [61]. 
 
1.2.6. Primary recovery methods 
Development of flexible alternative platform and advancement in upstream 
processing has led to the shift in focus on downstream processing to alleviate the 
bottlenecks to process large upstream output. Primary recovery is the first unit operation 
in a downstream process aimed at removal of cells and cell debris from the culture broth 
and clarification of the cell culture supernatant that contains the product. The efficiency 
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of chromatographic separations is largely dependent on initial steps involving 
precipitation procedures. The clarification step is traditionally performed by 
centrifugation and filtration. However, the presence of the high solid content and 
heterogeneous solution of soluble and insoluble components in the fermentation broth 
makes the primary recovery a significant challenge. Hence there is a dire need to explore 
additional precipitation/flocculation based pretreatment for improving clarification, 
yield, and process robustness. 
The pretreatments are based on selective precipitation of target protein or host 
impurities.  The number and distribution of charges, hydrophilic and hydrophobic 
residues on the surface of the protein molecule, size and shape of the molecule are some 
key features that determine its solubility and hence its tendency to precipitate in a given 
solvent (Figure 2). The protein solubility can be altered by manipulating the solvent 
properties like it’s ionic strength, pH, and by addition of organic solvents, polymers or 
combination of these together with temperature variation [72]. 
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Figure 2. Distribution of charge and hydrophobic patches over surface of a typical 
protein. 
 
The most common type of precipitation for proteins is salt induced precipitation. 
At low concentration of the salt, solubility of the proteins usually increases slightly 
(salting in). But at high concentrations of salt, the solubility of the proteins decreases 
sharply (salting out) and the proteins precipitate out. The addition of salt in high 
concentration diminishes electrostatic repulsion between similarly charged groups at the 
protein surface and disturbs the structure of water molecules around the protein 
molecule. Salt ions compete with protein globules for water and, eventually, at a 
sufficiently high concentration, strip the latter of aqueous shell, resulting in protein 
precipitation. The most effective salts are those with multiple-charged anions such as 
sulfate, phosphate, citrate; for cations monovalents ions like NH4
+, Na+ are used. 
Because of higher solubility in the wide temperature range of 0-30°C and lower density 
of the saturated solution (in comparison with the other salts), ammonium sulfate is 
preferred over other useful salts [73]. Ammonium sulfate precipitation has been used to 
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condition green tissue extracts including tobacco leaves extract for purification of IgG 
[74], tobacco cell suspension for purification of GFP-fusion protein [75], rice cell 
suspension for purification of human serum albumin (HSA) [76], etc. It removes native 
host cell proteins, rubisco, aggregates, and cell debris [77]. 
Another method of precipitation is isoelectric precipitation by altering the pH of 
the solution. At the isoelectric point of the protein, where the net charge on a protein is 
zero, the electrostatic repulsions between molecules are at a minimum and result in 
aggregation due to predominating hydrophobic interactions. At a pH below their pI, 
proteins carry a net positive charge; above their pI they carry a net negative charge. The 
pI of different proteins is different, which imparts selectivity in precipitation. The 
various factors which affect the precipitation include the stability of the target protein at 
the desired pH, the choice of acid or base and the way of addition of acids or bases [73]. 
Acidic precipitation (isoelectric) has been used for removing phenolics and green 
pigments from Lemna extracts containing IgG [63, 69], reducing phytic acid 
concentration in rice seed extracts containing human lysozyme [78], reducing rubisco 
and green pigments of tobacco leaves extracts containing IgG [79]. 
Flocculation by polymer precipitation has been another popular alternative to salt 
and pH based precipitation. Proteins can be precipitated with nonionic water soluble 
polymers like PEG and synthetic or natural polyelectrolytes like PEI or chitosan 
respectively. There are various mechanisms involved in polymer precipitation but the 
basic principle is mainly based on electrostatic attraction. Polyelectrolytes absorb to a 
particle (cell and cell debris) to create an oppositely charged patch on its surface. This 
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patch can then adhere to a bare patch on an opposing particle surface due to electrostatic 
attraction [73]. Strongly cationic polymers are more effective at flocculating cells, 
whereas neutral and anionic polymers are often ineffective [80]. The charge, MW and 
concentration of the polyelectrolyte, ionic strength, pH and concentration of 
macromolecule are crucial factors in polymer precipitation [73]. Polyelectrolyte 
precipitation with polyethyleneimine (PEI) has been successful in removing large 
amounts of native tobacco impurities as well as ensuring a high recovery and 
concentration of an acidic recombinant protein from tobacco [81]. 
Chitosan is another popular flocculant used in extract clarification due to a 
number of advantages such as it is produced from non-mammalian sources (typically 
arthropod shells), and is inexpensive and available in a highly purified form that is low 
in heavy metals, volatile organics and microbial materials. It is a cationic linear polymer 
of beta-(1–4) linked D-glucosamine monomers generated by the chemical deacetylation 
of chitin [80, 82, 83]. Chitosan, has been used for the removal of nucleic acids [84], the 
defatting of protein hydrolysates [85], the flocculation of E. coli cell debris and cell 
homogenate [83, 86] and the flocculation of yeast [87], bacteria [82] and algae [88]. 
There is a notable effect of chitosan concentration, sodium chloride concentration and 
pH on chitosan flocculation of cells, cell debris and particulates [89]. The underlying 
mechanism of flocculation likely involves electronic interaction between chitosan and 
charged cellular debris, followed by additional interactive forces such as hydrogen 
bonding [80]. 
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1.3. Objectives 
 
The objective of the proposed research was to develop technologies and 
processes for efficient production and purification of single chain antibody fragment 
from chloroplast of the eukaryotic algae C. reinhardtii. This project determined the 
process conditions and evaluated bioprocessing challenges for algae growth, expression, 
extraction and purification of single chain antibody from C. reinhardtii. The specific 
objectives of the research study were: 
1. To optimize cultivation conditions of C. reinhardtii to achieve maximum growth rate 
and accumulation of αCD22 scFv and Pfs25 in its chloroplast. 
2. To optimize light induction to achieve maximum accumulation of αCD22 scFv in the 
chloroplast. 
3. To evaluate extraction conditions for maximum recovery of αCD22 scFv in the algae 
extract. 
4. To evaluate different primary recovery methods for clarification of algae extract. 
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CHAPTER II 
LIGHT-INDUCED PRODUCTION OF AN ANTIBODY FRAGMENT AND 
MALARIA VACCINE ANTIGEN FROM CHLAMYDOMONAS REINHARDTII* 
 
2.1. Introduction 
 
The possibility of producing complex and diverse therapeutic proteins, such as 
monoclonal antibodies, antibody conjugates and vaccine antigens, in the chloroplast of 
Chlamydomonas reinhardtii has been reported [3-6, 16, 90]. The potential of microalgae 
to produce recombinant protein was previously reported [4-6, 16, 90]. Simple growth 
requirements, rapid growth and scalable production makes the unicellular eukaryotic 
green algal, Chlamydomonas reinhardtii, an attractive alternative, especially for 
complex therapeutic proteins that are not efficiently expressed in other heterologous 
systems. The expression of molecules that are not glycosylated or that do not require 
glycosylation for function are best suited for chloroplast expression in C. reinhardtii. 
Examples include antibody fragments, anthrax toxin blocking IgG [70], immunotoxins  
and transmission-blocking malaria vaccines (TBV) [91]. Although the expression, 
authenticity and activity of complex recombinant proteins in microalgae chloroplast are 
important prerequisites, one has to establish that these molecules can be produced at a 
                                                 
*This chapter is reprinted with the permission from “Light-Induced Production of An 
Antibody Fragment and Malaria Vaccine Antigen from Chlamydomonas reinhardtii” by 
Neera Munjal, Andrea Juliana Garzon Sanabria, Katelyn Wilson Quinones, James 
Gregory and Zivko L. Nikolov, 2014. Processes, 2, 625-638; doi:10.3390/pr2030625, 
Copyright [2014] by MDPI 
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competitive cost [61]. The aim of this study was to identify and evaluate variables that 
affect the accumulation and extraction of recombinant proteins produced in algal 
chloroplast. 
Plasmodium falciparum surface protein 25 (Pfs25TBV/Pfs25) [5] and single-
chain antibody fragment (αCD22 scFv) [6] were chosen as representative therapeutic 
protein molecules that have been produced in the chloroplast of C. reinhardtii. Pfs25 is a 
structurally complex, aglycosylated outer membrane protein and a leading subunit TBV 
candidate for malaria. The chloroplast of C. reinhardtii is a particularly attractive 
location for the production of aglycosylated therapeutic molecules, like Pfs25, that 
require eukaryotic-like machinery for proper folding and disulfide bond formation. The 
antibody fragment (αCD22 scFv) recognizes the CD22 B-cell surface epitope and has 
been used to generate fully-functional antibody-toxin chimeric proteins [6, 21]. 
Expression of these genes is regulated by the psbA promoter in psbA-deficient C. 
reinhardtii strains, which are non-photosynthetic, because the psbA gene product D1 is 
required for photosynthesis. This specific promoter and strain combination was made 
because it resulted in the highest levels of recombinant protein accumulation in C. 
reinhardtii [19, 23] and allows for the decoupling of heterotrophic growth and light-
induced gene expression. 
While many studies in C. reinhardtii have demonstrated light-induced gene 
expression [92-94], few have demonstrated the profound effect it can have on 
recombinant protein accumulation. Previous studies [95] established that a high cell 
density reduces light transmission in growing cultures and negatively affected 
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recombinant protein accumulation. Recent reports indicate that, in addition to the cell 
shading effect (reduced light transmission), the size of the synthesized molecule is also 
an important light induction variable. For example, a 5–8-h light induction time was 
used for Pfs25 using a photon irradiance of 5000 lux (68 μmol m−2 s−1 [5], whereas the 
CtBx-Pfs25 fusion protein required a 24-h induction time at the same irradiance level 
[96]. The larger of the two proteins, a monoclonal antibody-toxin conjugate, required a 
96-h light exposure at 10,000 lux (135 μmol m−2 s−1) [6]. Therefore, the effect of light 
exposure conditions (time and irradiance levels) on recombinant protein accumulation is 
a critical issue. 
The objective of this study is to provide a quantifiable account of light-induced 
recombinant protein accumulation in transgenic C. reinhardtii. Specifically, we wanted 
to determine the process conditions that could maximize C. reinhardtii biomass 
concentration and recombinant protein accumulation. Pfs25 (25 kDa) and αCD22 scFv 
(30 kDa) have similar molecular weights and, thus, reduce the potential effect of 
molecular size on light-induced accumulation. 
 
2.2. Materials and Methods 
 
2.2.1. Gene constructs for αCD22 scFv and Pfs25 
In both constructs, the endogenous psbA locus was replaced by Pfs25 or αCD22 
scFv via direct homologous recombination. Thus, transgene expression in these strains is 
regulated by the psbA promoter and the 5' and 3' untranslated regions (UTRs) and, 
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therefore, is light inducible. A kanamycin resistance cassette was incorporated for 
selection. In the case of αCD22 scFv, the variable domains of a human antibody against 
the B-cell surface antigen CD22 were separated by a linker consisting of four glycines 
and a serine repeated four times (4× G4S) to create an scFv [6]. Both of the gene 
cassettes (αCD22 scFv and Pfs25) were ligated with a sequence coding for a 1× FLAG 
peptide (DYKDDDDKS) and separated by a sequence that encodes a tobacco etch virus 
(TEV) protease cleavage site (ENLYFQG) [5]. 
 
2.2.2. Cultivation of recombinant Pfs25 and αCD22 scFv Chlamydomonas reinhardtii 
strains 
Algal biomass from a single agar plate (Tris-Acetate-Phosphate TAP agar with 
150 μg/mL kanamycin) was transferred to 100 mL of TAP media without kanamycin 
and grown for 3 days. A subsequent volumetric culture scale up was performed using 
10% inoculum in the exponential phase (100 mL) in 1 L of fresh TAP media containing 
25 μg/mL kanamycin. One-liter cultures were grown heterotrophically (in the dark) for 5 
days, reaching ~4 to 5 × 105 cells/mL. For resuspension experiments at the end of the 
fifth day, the biomass from 1-L cultures was resuspended in 1-L of fresh TAP media 
containing 25 μg/mL kanamycin and grown for 1 day, reaching about 106 cells/mL. The 
latter cultures were then exposed to light to induce recombinant protein synthesis. 
Control experiments without resuspension were performed under the same time and light 
regimes. For each recombinant protein, three replicate batches were grown in different 
conditions (resuspension vs. non-resuspension) followed by light induction. Cell growth 
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and cell concentration were monitored daily by counting cells using a hemocytometer 
(Bright Line, Hausser Scientific, Horsham, PA, USA) and by measuring the optical 
density at a 750-nm wavelength using a DU640 spectrophotometer (Beckman Coulter, 
Brea, CA, USA). 
 
2.2.3. Effect of light duration and light intensity on light-induced production of αCD22 
scFv 
The effect of photon irradiance flux on the accumulation of αCD22 scFv was 
evaluated in cultures grown under heterotrophic conditions followed by resuspension to 
a final cell concentration of ~106 cells/mL, as described above. Cultures were exposed to 
light for 12 h and 24 h consecutively at a photon irradiance of 101 μmol m−2 s−1 and 300 
μmol m−2 s−1. Recombinant protein was extracted and quantified by anti-FLAG affinity 
purification, as described below. 
 
2.2.4. Protein extraction 
C. reinhardtii cultures producing recombinant proteins were grown in liquid 
media until they reached the desired cell concentration of ~106 cells/mL. At the end of 
the light exposure period, cells were harvested by centrifugation at 10,000× g for 15 min 
at 4°C. Pelleted algal biomass was washed with fresh TAP media, weighed and then 
resuspended at a 1:5 biomass-to-lysis buffer ratio (50 mM Tris-HCl, 400 mM NaCl and 
0.5% Tween, pH 8.0). The buffer contained a complete protease inhibitor cocktail 
(Roche, Mannheim, Germany) dissolved in 200 mL of the buffer. Algal cells were lysed 
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by sonication for 8 min with 30 s on/off intervals at 4 °C using a sonicator (Sonifier 250, 
Branson, Danbury, CT, USA) at 30% output control and 30% duty cycle with a micro 
probe (1/8” microtip A3-561 Branson, Danbury, CT, USA). Cell lysates were 
centrifuged (10,000× g for 10 min) to produce clarified crude extracts. 
 
2.2.5. Protein analysis 
Filtered algal crude extract and purified samples were analyzed by SDS-PAGE 
and western blot, and the total eluted protein was determined by the Bradford assay [97]. 
Total soluble protein from crude extracts and purified samples were quantified using the 
microplate protocol (working range from 1 to 25 μg/mL and 25 to 1,500 μg/mL) 
Coomassie plus (Bradford) assay kit (Thermo Scientific, Waltham, MA, USA). 
Absorption at 595 nm was measured using the VERSA max microplate reader 
(Molecular Devices, Sunnyvale, CA, USA). 
NuPAGE Novex Bis-Tris pre-cast gradient gels (4%–12%) from Invitrogen™ 
(Carlsbad, CA, USA) (1.5 mm × 10 wells), (Cat No. NP0335BOX) were used for SDS-
PAGE electrophoresis. Reducing buffer was prepared using LDS sample buffer (4×) 
(NuPAGE NP0007) containing 10% of reducing agent (Cat No. NP0004). Reduced 
samples were prepared using a 1:4 ratio reducing-buffer: sample and heated at 70°C for 
10 min. MES SDS Running Buffer (20×) (Cat No. NP0002) stock solution was used to 
prepare 1× running buffer in reverse osmosis water. Antioxidant (NuPAGE NP0005, 
Invitrogen™, Carlsbad, CA, USA) was added to ensure reduced samples during 
electrophoresis. Gels were run for 35 min at a constant voltage (200 V). For SDS 
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analysis, the gels were stained in Coomassie™ (Thermo Fisher Scientific, Waltham, 
MA, USA) G-250 stain (Cat No. LC6065) for 3 h, followed by destaining in RO water. 
For western blot analysis, the gel was transferred to nitrocellulose membranes using the 
iBlot® 7-Minute Blotting System, Life Technologies Corporation (Carlsbad, CA, USA). 
After protein transfer to a nitrocellulose membrane, the membrane (free sites) 
was blocked with 2.5% non-fat milk in TBS containing 0.05% Tween 20 at pH 7.5 
buffer for 1 h to prevent nonspecific binding of the detection antibodies. FLAG-tagged 
recombinant proteins (αCD22 scFv and Pfs25) were detected by using anti-FLAG M2-
AP (alkaline phosphatase conjugated) antibody from Sigma Aldrich (Cat No. A9469, St. 
Louis, MO, USA) at a concentration of 1:1000. After incubation with the antibody for 1 
h, the membrane was washed with TBS containing 0.05% Tween 20 at pH 7.5; buffer 
and blots were visualized (developed) with nitro-blue tetrazolium (NBT) and  
5-bromo-4-chloro-3’-indolyphosphate p-toluidine salt (BCIP) (Sigma FAST B5655, St. 
Louis, MO, USA) dissolved in 10 mL of filtered RO water. 
 
2.2.6. FLAG affinity purification 
Crude extracts were filtered using a polyethersulfone (PES) 0.45-μm filter and 
mixed with anti-FLAG affinity resin (Sigma Aldrich A4596, St. Louis, MO, USA) 
equilibrated in the same lysis buffer used for protein extraction. Approximately 1 mL of 
resin was used per every 4 g of wet algal biomass. Binding of the recombinant protein to 
the affinity resin was performed for 2 h at 4°C by continuous end-over-end mixing in a 
Glas-Col rotor (Glas-Col LLC, Terre Haute, IN, USA) at ~33 rpm (40% speed control). 
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Affinity resin was washed with 10 column volumes (CV) of lysis buffer followed by 3 
column volumes of lysis buffer without Tween. The washed FLAG resin was transferred 
into Bio Spin disposable chromatography columns (Bio Rad, Cat No. 732-6008, 
Hercules, CA, USA) for protein elution at room temperature. Recombinant protein was 
eluted at pH 3.5 using 5 CV of 100 mM glycine buffer, pH 3.5 that contained 400 mM 
NaCl. Eluted protein fractions were collected in 5 tubes containing a predetermined 
amount of 1M Tris-HCl, pH 8.0, to immediately increase the pH of the eluted protein 
and avoid protein denaturation. Typically, three elution fractions (E2 to E4) were used 
for the estimation of purity and yield, although some losses occurred by not taking into 
account E1 (Elution Fraction 1). By pooling these three fractions, more than 80% of 
extracted FLAG-tagged proteins were recovered. Extraction buffer and all of the 
materials used, including the sonication probe (1/8” microtip A3-561 Branson, Danbury, 
CT, USA), were cooled in advance. 
The FLAG affinity purification method was used as a convenient analytical tool 
to determine the recombinant extraction yield. The resin was added in sufficient amounts 
to bind all available FLAG fusion protein present in clarified extracts. Cell debris and 
supernatants at the end of the batch adsorption period were regularly analyzed by 
western blotting to assure complete extraction and adsorption, respectively. Although 
minor recombinant protein losses have occurred during resin washing and pH 3.5 elution 
from the anti-FLAG resin, this determination of recombinant protein concentration was 
considered appropriate for estimating recombinant protein in crude extracts. 
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2.2.7. Statistical analysis 
Design Expert software (Version 9, Stat-Ease, Inc., Minneapolis, MN, USA, 
2014) was used for the experimental design and analysis. The statistical significance of 
the models was evaluated by the analysis of variance (ANOVA). Effects with more than 
95% of significance (95% confidence interval), that is effects with a p-value lower than 
0.05, were significant. Significantly different means (p < 0.05) were separated by 
Tukey’s test. 
 
2.3. Results and Discussion 
 
2.3.1. Algae cultivation and accumulation of αCD22 scFv and Pfs25 
The optimization of algal growth and induced expression conditions could 
significantly enhance recombinant protein accumulation. Maximal biomass 
accumulation was achieved after four to five days of continuous growth under 
heterotrophic conditions (no light exposure) with the cell concentration reaching 5 to 6 × 
105 cells/mL (Figure 3). In order to further increase the cell concentration and to provide 
sufficient nutrients for the subsequent induction phase, cells were resuspended in fresh 
media at the end of the fifth day and allowed to grow for 24 h before the induction (light 
exposure) period (Figure 3). 
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Figure 3. Heterotrophic growth curves of Chlamydomonas reinhardtii expressing 
αCD22 scFv and Pfs25. The effect of resuspension, spiking and light exposure (101μmol 
m-2s-1) on cell concentration. Values indicated are average of 3 replicates. TAP: Tris-
Acetate-Phosphate. 
 
Twenty-four hours after resuspension (Day 6), the cell number of resuspended 
cultures increased almost two-fold (1.8-fold for αCD22 scFv and 1.5-fold for Pfs25) 
compared to non-resuspended ones (Figure 3). The exposure of the cultures to light for 
24 h (Day 7) increased cell concentrations of resuspended and non-resuspended cultures 
proportionally, maintaining the two-fold difference. The variability in cell concentrations 
for resuspended cultures could be due to different cell adaptation periods between (lag 
phase) the three batches after resuspension. 
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We tested both 24 h and 48 h incubation after resuspension and found that 24 h 
was optimal, as no additional increase in cell number was observed. The increase in 
culture pH to 8.0 near the end of the exponential phase (Day 5) reflects the depletion of 
acetate (carbon source); therefore, the increase in cell number during resuspension could 
be attributed to the replenishment of the carbon source in the media. We confirmed the 
above hypothesis by spiking the culture with sodium acetate (1.68 g/L), which also 
resulted in about a two-fold increase in the cell concentration. The growth curve of C. 
reinhardtii after spiking with sodium acetate followed a similar trend as resuspension 
with fresh TAP media (Figure 3). Thus, cell resuspension is not necessary, and fed-batch 
cultivation with only acetate addition would be a feasible method to increase algal 
biomass. At the end of Day 6, wet biomass of resuspended cultures increased 2.65-fold 
for αCD22 scFv and three-fold for Pfs25 compared to the non-resuspended cultures. The 
reason for the higher fold increase in wet biomass compared to cell concentration 
reflects the increase in the cell mass (i.e., cell size) with resuspension. 
Total biomass, as measured by optical density at 750 nm, as well as extracted 
soluble protein (TSP) in cultures increased with increased light exposure, which agrees 
with the fact that RuBisCO and other light-activated enzymes and pigments are being 
synthesized under light conditions [50]. In C. reinhardtii, the genes encoding the light 
harvesting chlorophyll a/b-binding proteins (LHCPs) and the oxygen evolving enhancer 
(OEE) complex proteins are expressed when cells are shifted from the dark into white 
light [98]. During light exposure, there was no significant increase in cell concentration, 
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probably due to a higher energy demand for carbon fixation, since the carbon uptake flux 
is directed through the Calvin cycle [50, 99]. 
We investigated the effect of resuspension and light induction on αCD22 scFv 
and Pfs25 synthesis and accumulation, because the aim of increasing the cell density was 
to increase the recombinant protein accumulation per liter of culture. The effect of 
resuspension on the amount of purified αCD22 scFv and Pfs25 is shown in Figure 4a. 
The increase of cell concentration resulted in a 2.8-fold increase of αCD22 scFv and a 
2.8-fold increase of Pfs25 protein eluted from the affinity resin. 
These results also suggest a correlation between total soluble protein and 
recombinant protein accumulation in crude extracts (Figure 4b). Because resuspension 
has a positive effect on the overall growth of the algal cells, replenishment of the media 
also results in an increase in total soluble protein. In the case of αCD22 scFv, the 
increase in purified recombinant protein amount was synchronous with the increase in 
total soluble protein (TSP). As expected, resuspension resulted in a similar fold increase 
in recombinant protein accumulation (2.8 ± 0.9) and total soluble protein accumulation 
(2.9 ± 0.4). However, Pfs25 showed a greater fold increase in purified recombinant 
protein concentration (2.8 ± 0.5) compared to the (1.1 ± 0.2) fold increase in total 
soluble protein accumulation. The higher fold increase in the FLAG-purified Pfs25 
protein concentration compared to αCD22 scFv might have been the result of Pfs25 
aggregation (Figure 5a, b), which often reduces recombinant protein susceptibility to 
proteases [100]. 
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Figure 4. The effect of resuspension on (a) purified recombinant protein (αCD22 scFv 
and Pfs25) and (b) total soluble protein concentrations. Values indicated are average of 3 
replicates. 
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2.3.2. Purification and analysis of recombinant proteins 
Recombinant proteins were purified from clarified crude lysates by FLAG 
affinity adsorption and analyzed by SDS-PAGE and western blotting (Figure 5a, b). The 
presence bands of negligible intensity in the supernatant after 2 h of incubation (Lane 3) 
and washes before elution (Lanes 4–5) at the same size as Pfs25 confirm the efficient 
binding of FLAG-tagged Pfs25 to the anti-FLAG affinity resin. SDS-PAGE gels and 
total eluted protein analysis by the Bradford assay indicated that the majority of purified 
Pfs25 (25 kDa band) eluted in Fractions 2, 3 and 4 (Lanes 7–9). These two fractions 
typically contained approximately 80% of the total eluted recombinant protein from the 
resin. The eluted fractions, in both the SDS-PAGE and western blot, show the presence 
of aggregates, even under reducing conditions (~50 kDa to 100 kDa bands) in Figure 5a. 
 
 
 
 
 
 32 
 
 
Figure 5. (a) Coomassie-stained SDS-PAGE of reduced C. reinhardtii Pfs25 purified 
with FLAG affinity chromatography. Lane 1: molecular weight marker (kDa); Lane 2: 
10X diluted clarified algae extract; Lane 3: 10X diluted supernatant after 2 h of binding 
with FLAG resin; Lanes 4–5: washes before elution; Lanes 6 to 10: pH 3.5 eluted 
fractions; (b) Western blot analysis of C. reinhardtii  Pfs25 using anti-FLAG-AP 
conjugated antibody. Lane 1: molecular weight marker (kDa), Lane 2: 10X diluted 
clarified initial extract; Lane 3: 10X diluted supernatant after 2 h of binding with FLAG 
resin; Lanes 4 and 5: washes before elution, Lanes 6 to 10: pH 3.5 eluted fractions. 
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The detection of aggregates was not surprising, because Pfs25 is a membrane 
protein, and similar aggregation has also been observed in yeast-produced Pfs25 [101, 
102]. In spite of Pfs25 aggregation, FLAG-affinity purified Pfs25 multimers generated 
an immune response and elicited antibodies with significant levels of transmission 
blocking activity [5]. 
The analyses of purified αCD22 scFv revealed no significant aggregation in the 
eluted fractions by SDS-PAGE (Figure 6a, Lanes 6 to 10) and western blot (Figure 6b). 
Similar to Pfs25, the insignificant losses in the supernatant (Lane 2) and washes (Lanes 
3–4) confirms the efficient binding and elution of FLAG-tagged αCD22 scFv from the 
anti-FLAG affinity resin. A major 30-kDa band was detected by the SDS-PAGE gel 
(Figure 6a) and western blot (Figure 6b). Western blot (Figure 6b, Elution 2) revealed 
the presence of minor degradation products of 14 kDa and 17 kDa in size. 
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Figure 6. (a) Coomassie-stained SDS-PAGE gels of reduced Chlamydomonas 
reinhardtii αCD22 scFv purified with FLAG affinity chromatography. Lane 1: 
molecular weight marker (kDa); Lane 2: 10× diluted clarified initial extract; Lane 3: 10× 
diluted supernatant after 2 h of binding with FLAG resin; Lane 4: wash 1 before elution 
10×; Lane 5: wash 2 before elution; Lanes 6 to 10: pH 3.5 eluted fractions; (b) Western 
blot analysis of C. reinhardtii CD22 scFv using anti-FLAG-AP conjugated antibody. 
Lane 1: molecular weight marker (kDa); Lane 2: clarified initial extract; Lane 3: 
supernatant after 2 h of binding with FLAG resin; Lane 4: wash 1 before elution; Lane 5: 
wash 2 before elution; Lanes 6 to 10: pH 3.5 eluted fractions.  
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2.3.3. Light-induced accumulation of αCD22 scFv 
We observed that the recombinant protein accumulated did not increase 
significantly when the wet biomass concentration increased beyond 4 g/L (>106 
cells/mL), and some batches even reported somewhat lower recombinant protein 
accumulation. The significant (p < 0.05) increase in the cell number that occurred after 
resuspension raised the question of the cell shading effect on protein accumulation. 
Because light induction is a unique feature of psbA-driven gene constructs, we 
hypothesized that recombinant production would be affected by the amount of light 
(total energy) reaching each cell in the culture. To determine the optimal light conditions 
required to overcome shading and maximize recombinant protein accumulation, we used 
only αCD22 scFv strain, because extensive aggregation of Pfs25 could obscure the effect 
of delivered light flux on the recombinant protein yield. 
A 23 full factorial design was performed to determine the effect of the light 
intensity, light duration and light placement on the volumetric concentration of 
recombinant protein αCD22 scFv. The optimal cell concentration used for light 
induction was 1 × 105 cells/mL. The placement of the light source (one vs. two sides) did 
not have a significant effect on the recombinant protein accumulation; however, there 
was a significant effect (p < 0.05) of light duration and light intensity on recombinant 
protein accumulation. Because preliminary data with both Pfs25 and αCD22 scFv 
showed no substantial protein accumulation beyond 24 h of light exposure at 101 μmol 
m−2 s−1, we restricted the further investigation to 12 h and 24 h of light exposure and two 
levels of light intensity: 101 μmol m−2 s−1 and 300 μmol m−2 s−1. The effect of these two 
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variables is summarized in Table 1. It is evident from the data that a 24-h light duration 
at both light intensities was optimal for maximum recombinant protein accumulation per 
gram of wet biomass and unit culture volume. At a light intensity of 101 μmol m−2 s−1, 
21.2 ± 1.8 μg/g of αCD22 scFv was recovered after 12 h of light exposure compared to 
35.1 ± 5.8 μg/g after 24 h of light exposure. A similar time effect was observed at 300 
μmol m−2 s−1; 26.6 ± 4.3 g/g of αCD22 scFv were recovered after 12 h and 61.5 ± 14 
μg/g after 24 h. Interestingly, the recombinant protein recovered after 12 h of exposure at 
a higher light intensity of 300 μmol m−2 s−1 (26.6 ± 4.3 μg/g) was not significantly 
different from the 12 h of light exposure at 101 μmol m−2 s−1 (21. 2 ± 1.8 μg/g). 
However, after 24 h, the difference in αCD22 scFv accumulation at 300 μmol m−2 s−1 
became twice as much as that at 101 μmol m−2 s−1, indicating that both the light intensity 
and duration of exposure were important factors for the synthesis of recombinant 
protein. The same conclusion could be reached by comparing αCD22 scFv volumetric 
concentrations after 12 and 24 h at 300 μmol m−2 s−1 and 101 μmol m−2 s−1, respectively. 
Interestingly, the effect of the same two factors was different for total soluble protein. 
Host proteins, such as RuBisCO and other light-activated enzymes listed under TSP in 
Table 1, were synthesized mainly during the first 12 h of light exposure, and the TSP 
concentration did not significantly change during the next 12 h. These data suggest that 
native host proteins were synthesized faster than the recombinant protein and that the 12-
h period of light exposure was not sufficient for maximal accumulation of αCD22 scFv. 
These results corroborate previous data indicating that the translation of the psbA 
promoter is a rate-limiting step for recombinant protein expression in transgenic C. 
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reinhardtii [52]. The increase of αCD22 scFv accumulation (% TSP) after 24 h at both 
light intensities (Table 1) reflects the effect of light duration and intensity on continued 
αCD22 scFv accumulation at constant total soluble protein. The two-fold increase of the 
recombinant protein fraction in the extracted soluble protein is a desirable product 
recovery outcome, which is equivalent to achieving a two-fold purification [61]. 
 
Table 1. The effect of light intensity and duration on biomass harvested, total soluble 
protein (TSP) and αCD22 scFv protein production. The values given are averages from 
three replicates ± standard deviations. a,b For each observation, means within a column 
that are not followed by a common superscript letter are significantly different (p < 
0.05); x,y means within a row that are not followed by a common subscript letter are 
significantly different (p < 0.05). 
Photosynthetic Photon Flux 
(PPF) 
Duration 101 μmol m−2 s−1 300 μmol m−2 s−1 
Biomass (g) 
12 h x 4.0 
a ± 0.01 x 4.9 
a ± 1.5 
24 h x 4.0 
a ± 0.01 x 5.3 
a ± 1.0 
TSP in algae extract (μg/mL) 
12 h x 5939 
a ± 257 x 5485 
a ± 802 
24 h x 6840 
a ± 1167 x 5248 
a ± 415 
αCD22 scFv in wet biomass 
(μg/g) 
12 h x 21.2 
a ± 1.8 x 26.6 
a ± 4.3 
24 h x 35.1 
b ± 5.8 y 61.5 
b ± 14 
αCD22 scFv volumetric conc. 
(μg/L) 
12 h x 84.7 
a ± 7.1 x 135 
a ± 66 
24 h x 140 
a ± 20 y 314 
b ± 20 
αCD22 scFv (%TSP) 
12 h x 0.07 
a ± 0.01 x 0.1 
a ± 0.03 
24 h x 0.12 
a ± 0.03 y 0.23 
b ± 0.05 
 
2.4. Summary 
 
This study provides an account of factors that affect the accumulation of two 
recombinant proteins in C. reinhardtii chloroplast. Cultivation variables of C. 
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reinhardtii, such as light-induction time and intensity, replenishment with fresh media 
and culture age, had a significant effect on biomass and recombinant protein 
accumulation. 
Maximum biomass accumulation of transgenic C. reinhardtii was achieved after 
resuspending the cells in fresh TAP media after five days of heterotrophic growth, which 
resulted in a 2.8-fold increase in the culture concentration of recombinant therapeutic 
proteins αCD22 scFv and Pfs25, but this could also be achieved by adding acetate. There 
was a correlation between total soluble protein and recombinant protein accumulation in 
crude extracts for αCD22 scFv, but not Pfs25. Resuspension resulted in a similar fold 
increase in αCD22 scFv accumulation (2.8 ± 0.9) and total soluble protein accumulation 
(2.9 ± 0.4). 
There was also a significant effect of light duration and intensity on the psbA 
regulated expression of αCD22 scFv protein in the chloroplast. The exposure of light of 
300 μmol m−2 s−1 for 24 h resulted in a maximum culture concentration of αCD22 scFv 
(314.0 ± 20 μg/mL), which is a two-fold increase compared to 101 μmol m−2 s−1. 
Decoupling of the cell growth and light-induced production of Pfs25 and αCD22 scFv 
allowed us to demonstrate that native C. reinhardtii proteins accumulate faster (12 h) 
during the light phase than recombinant proteins, which needed 24 h of light exposure. 
Thus, an increase in light intensity to 300 μmol m−2 s−1 not only increased the 
recombinant protein production, but also led to an efficient product recovery with a two-
fold increase of the recombinant protein fraction in the extracted soluble protein. 
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The two proteins were efficiently purified by FLAG affinity adsorption with 
minimal losses (less than 20%) as judged by western blots. Overall, resuspension and 
light optimization resulted in a six-fold increase in the recovered recombinant protein in 
the chloroplasts of C. reinhardtii. 
 40 
 
CHAPTER III 
EVALUATION OF EXTRACTION CONDITIONS AND PRETREATMENT 
METHODS FOR PRODUCTION OF AN ANTIBODY FRAGMENT FROM 
CHLAMYDOMONAS REINHARDTII 
 
3.1. Overview 
 
 Advancement in upstream processing titers and introduction of novel platforms 
for recombinant protein production has led to more complex product feed streams to 
chromatography (culture broths and cell lysates). Because downstream processing of 
therapeutic protein products can account for a significant portion of the total 
manufacturing costs, the development of efficient and selective recovery and purification 
processes as early as possible is essential for favorable economics [94].  
 Primary recovery is the first stage in downstream processing aimed at 
clarification of cell culture and cell lysates to yield clarified feed suitable for 
chromatography.  Traditionally, downstream processing of therapeutic proteins has been 
designed to place nearly all of the purification capabilities on chromatography steps with 
the clarification steps signed exclusively for cell and cell debris removal. Primary 
recovery steps for therapeutic products typically consist of cell or cell debris removal by 
centrifugation followed by depth filtration and sterile filtration before capture 
chromatography. Clarification of cell lysates during recovery of intracellular products 
could be challenging and the removal cell debris by centrifugation and depth filtration is 
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often not efficient and, in some cases, inadequate.  Recently, primary recovery of 
monoclonal antibodies from high-titer mammalian cell cultures have faced similar 
efficiency challenges that led to investigating pretreatment methods (flocculation and 
precipitation) for improving clarification, yield, and process robustness [80, 103]. 
 Green microalgae are being currently evaluated as a potential platform for 
expressing variety of non-glycosylated protein products [2, 3, 5, 6, 16, 20, 70] and 
recombinant protein recovery and purification data are not available.  Most recombinant 
proteins are best expressed and localized in the algal chloroplast and in the absence of 
other relevant data, one can only assume that optimal target protein extraction and 
recovery from algal biomass would be similar in many respects to that from transgenic 
green tissues.  The protein release and extraction from transgenic biomass tissue is a 
critical recovery step because it dictates the total extract volume, recombinant protein 
concentration and purity, and the type and quantity of impurities that have to be removed 
during purification [64, 104]. During extraction, recombinant protein is often 
accompanied by the release of a variety of host cell proteins, DNA and other plant-
specific impurities such as chlorophyll pigments, alkaloids, and phenolics. Extraction 
conditions (temperature, pH, salt, detergents, biomass-to-buffer ratio) have been used to 
reduce interactions between the recombinant protein and cell debris, to protect 
recombinant protein from degradation, and hence maximize the recombinant protein 
yield [61, 64, 66-68, 105].  With exception of phenolics and alkaloids, green microalgae 
extracts resembles green leaf extracts and generated knowledge could be applicable to 
transgenic microalgae. 
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 Several pretreatment strategies like aqueous two-phase partitioning [106, 107], 
ammonium sulfate precipitation [74], isoelectric precipitation [69, 105] and polymer 
precipitation [84, 108] have been successful with the green tissue extracts. Low 
percentage ammonium sulfate (25–30%) precipitation is another common method for 
pretreatment of cell culture and green tissue homogenates [74]. Ammonium sulfate 
precipitation removed native plant proteins including the photosynthetic protein, ribulose 
bis-phosphate carboxylase/oxygenase (rubisco), aggregates, and cell debris [77]. In case 
of acidic precipitation, adjusting the pHs of leafy extracts and cell homogenates to <5.0 
precipitates the most abundant plant protein (rubisco), cell debris, as well as chlorophyll 
pigments attached to the protein and debris [77, 105]. Similar to ammonium sulfate 
precipitation, acid precipitation resulted in at least two-fold purification of a recombinant 
protein prior to the first chromatography column. Our lab has previously demonstrated 
that acidic (pH 4.5) precipitation of Lemna minor extracts containing IgG also removed 
phenolics and green pigments [69, 105].  
 Cationic polymers, PEI and chitosan, has been successfully used for flocculation 
of debris, cells and particulates [83, 88, 108]. Chitosan, has several unique properties 
that make this polysaccharide polymer particularly popular: it is inexpensive (∼$60/kg), 
biodegradable, non-toxic, tolerant to presence of salts in solution, and available as a food 
grade material that is low in heavy metals and volatile organics. [89]. Chitosan has been 
used for the removal of nucleic acids [84], the defatting of protein hydrolysates [85], the 
flocculation of E. coli cell debris and cell homogenate [83, 86] and the flocculation of 
yeast [87], bacteria [82] and algae [109, 110]. 
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 Although the pretreatments listed above have been used to reduce DNA, host 
protein or cell debris, flocculate cells and cell debris, none of the studies quantified the 
effect of selected pretreatments on debris removal, reduction of DNA, host cell proteins, 
pigments, etc.  In this study we compare three pretreatment methods and quantify their 
effect on recovery of single-chain antibody fragment (αCD22 scFv) [6] produced in the 
chloroplast of C. reinhardtii. Specifically, the aim was to select extraction conditions 
and pretreatment of lysates and clarified extracts for maximum reduction of impurities 
load without comprising the recovery of recombinant αCD22 scFv. 
 
3.2. Materials and Methods 
 
3.2.1. Gene constructs for αCD22 scFv 
 In the construct, the endogenous psbA locus was replaced by αCD22 scFv via 
direct homologous recombination. Thus, transgene expression in these strains is 
regulated by the psbA promoter and the 5’ and 3’ untranslated regions (UTRs) and, 
therefore, is light inducible. A kanamycin resistance cassette was incorporated for 
selection. The variable domains of a human antibody against the B-cell surface antigen 
CD22 were separated by a linker consisting of four glycines and a serine repeated four 
times (4×G4S) to create an scFv [6]. The gene cassettes (αCD22 scFv) was ligated with 
a sequence coding for a 1× Flag peptide (DYKDDDDKS) and separated by a sequence 
that encodes a Tobacco etch virus (TEV) protease cleavage site (ENLYFQG) [6]. 
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3.2.2. Cultivation of recombinant αCD22 scFv C. reinhardtii strains 
Algal biomass from a single Tris acetate phosphate agar plate containing 150 
µg/ml kanamycin) was transferred to 100 mL of TAP (Tris acetate phosphate) media 
without kanamycin and grown for 3 days. Subsequent volumetric culture scale up was 
performed using 10 % inoculum in the exponential phase (100 mL) in 1-L of fresh TAP 
media containing 25µg/mL kanamycin. One liter cultures were grown heterotrophically 
(in the dark) for 5 days reaching ~ 4 to 5 × 105 cells/mL.  At the end of the fifth day, the 
biomass from 1-L cultures was resuspended in 1-L of fresh TAP media containing 25 
µg/mL kanamycin and grown for 1 day reaching about 106 cells/mL.  The cultures were 
then exposed to light at 300 µmol m-2s-1 for 24 hours to induce recombinant protein 
synthesis. Cell growth was monitored daily by counting cells using a hemocytometer 
(Bright Line, Hausser Scientific, Horsham, PA) and measuring optical density at 750 nm 
wavelength using a Beckman Coulter (Brea, CA) DU640 spectrophotometer.  
 
3.2.3. Protein extraction 
C. reinhardtii cultures producing recombinant proteins were grown in liquid 
media until they reached the desired cell concentration of ~106cells/mL.  At the end of 
the light exposure period, cells were harvested by centrifugation at 10,000 ×g for 15 min 
at 4 ºC.  Pelleted algal biomass was washed with fresh TAP media, weighted, and then 
resuspended at 1:5 biomass-to-lysis buffer ratio 50 mM Tris-HCl, 400 mM NaCl, and 
0.5% Tween 20, pH 8.0. The buffer contained a complete protease inhibitor cocktail 
(Roche-Mannheim, Germany) dissolved in 200 mL of the buffer. Algal cells were lysed 
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by sonication for 8 min with 30 s on/off intervals at 4oC using sonicator (Sonifier 250, 
Branson, USA) at 30% output control and 30% duty cycle with a micro probe (1/8’ 
microtip A3-561 Branson, USA). Cell lysates were centrifuged (10,000 x g for 10 min) 
to produce cell-free extracts. 
For optimization of extraction conditions of αCD22 scFv, buffer composition 
(pH, NaCl, Tween 20) was varied depended on the extraction objective.  Two levels 
each for pH (4.5 and 8), NaCl (100 mM, 400 mM) and Tween 20 (0% and 0.5%) were 
tested. All buffers contained a complete protease inhibitor cocktail (Roche-Mannheim, 
Germany) dissolved in 200 mL of the buffer.  Cell lysates were centrifuged (10,000 x g 
for 10 min) and filtered with PES 0.45 µm syringe filter to produce clarified extracts. 
 
3.2.4. Pretreatment of cell-free extracts and cell lysates 
The cell lysate or cell-free extract obtained after sonication in optimum 
extraction buffer was subjected to three different primary recovery methods, i.e. 
ammonium sulfate precipitation, acidic precipitation and polymer 
flocculation/precipitation and each was compared to no pretreatment from the same 
batch. Each experimental study was performed in replicates. 
Ammonium sulfate (Sigma Aldrich Company, USA) precipitation was performed 
by adding the calculated amount of 3.6 M ammonium sulfate stock solution to the C. 
reinhardtii cell lysates or cell-free extracts to achieve the desired molar concentration 
(0.5M, 1.0M, 1.5M, 2 M). The lysates or cell-free extracts were then mixed (end over 
end) for 30 minutes at room temperature followed by centrifugation at 10000 x g for 10 
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min. The supernatants were filtered with PES 0.45 µm syringe filter and analyzed for 
host cell protein (HCP), DNA, chlorophyll, turbidity, and αCD22 scFv by methods 
discussed below. 
Acidic precipitation was performed by adding 0.5 N HCl (dropwise with gentle 
shaking) to C. reinhardtii cell lysates or cell-free extracts until the pH dropped to 4.5. 
Agitation was provided by end-over–end gentle mixing for 15 min, followed by 
centrifugation at 10000 x g for 10 min. The acidic supernatants were adjusted to pH 8 
with 1 N NaOH. The supernatants were filtered with PES 0.45 µm syringe filter and 
analyzed for host cell protein (HCP), DNA, chlorophyll, turbidity, and αCD22 scFv by 
methods discussed below. 
Polymer pretreatment was done with 10 mg/mL stock solution of chitosan in 1% 
acetic acid solution (Sigma Aldrich Company, USA).  The stock solution of chitosan 
was prepared by mixing chitosan in 1% acetic acid solution for 24 h at 60 rpm and room 
temperature.  Thirty milligrams of chitosan (3 ml stock) was added per gram of algae 
biomass followed by vortexing for 30 sec. The lysate pH was then adjusted to 5.0 with 
0.1 N HCl and mixed (end over end) for 30 minutes at room temperature. The cell lysate 
was then readjustment to pH 8.0 and centrifuged at 6000 x g for 10 min for precipitating 
out chitosan and chitosan bound debris and impurities from the extract. The supernatants 
were filtered with PES 0.45 µm syringe filter and analyzed for host cell protein (HCP), 
DNA, chlorophyll, turbidity, and αCD22 scFv by methods discussed below. 
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3.2.5. Protein analysis 
Filtered algal crude extract and purified samples were analyzed by SDS-PAGE, 
Western blot, and total eluted protein determined by Bradford assay [97]. Host cell 
protein/Total soluble protein from crude extract and purified samples were quantified 
using the microplate protocol (working range from 1 to 25 µg/mL and 25 to 1500 
µg/mL) Coomassie plus [97] assay kit (Thermo Scientific). Absorption at 595 nm was 
measured using the VERSA max microplate reader. 
NuPAGE Novex Bis-Tris pre-cast gradient gels (4 - 12 %) from InvitrogenTM 
(1.5 mm x 10 wells), (Cat no. NP0335BOX) were used for SDS-PAGE electrophoresis.  
Reducing buffer was prepared using LDS sample buffer (4X) (NuPAGE NP0007) 
containing 10% of reducing agent (Cat no. NP0004). Reduced samples were prepared 
using a 1:4 ratio reducing-buffer: sample and heated at 70 ºC for10 min. MES SDS 
Running Buffer (20X) (Cat no. NP0002) stock solution was used to prepare 1X running 
buffer in RO water. Antioxidant (NuPAGE NP0005) was added to ensure reduced 
samples during electrophoresis. Gels were run for 35 min at constant voltage (200 V).  
For SDS analysis, the gels were stained in CoomassieTM G-250 stain (Cat no. LC6065) 
for 3 hours followed by destaining in RO Water. For Western blot analysis, the gel was 
transferred to nitrocellulose membranes using iBlot® 7-Minute Blotting System, Life 
Technologies Corporation. 
After protein transfer to a nitrocellulose membrane, the membrane (free sites) 
was blocked with 2.5 % non-fat milk in TBS containing 0.05 % Tween 20 at pH 7.5 
buffer for 1 h to prevent nonspecific binding of the detection antibodies.  FLAG-tagged 
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recombinant proteins (αCD22 scFv and Pfs25) were detected by using anti-FLAG M2-
AP (alkaline phosphatase conjugated) antibody from Sigma Aldrich [40 A9469] at a 
concentration of 1:1,000.  After incubation with the antibody for 1 h, the membrane was 
washed with TBS containing 0.05 % Tween 20 at pH 7.5, buffer and blots were 
visualized (developed) with nitro-blue tetrazolium (NBT) and 5-bromo-4-chloro-3’-
indolyphosphate p-toluidine salt (BCIP) (Sigma FAST B5655) dissolved in 10 mL of 
filtered RO water. 
 
3.2.6. FLAG affinity chromatography 
Crude extracts were filtered using polyethersulfone (PES) 0.45 µm filter and 
mixed with anti-FLAG affinity resin (Sigma Aldrich A4596) equilibrated in the same 
lysis buffer used for protein extraction.  Approximately 1 mL of resin was used per 
every 4 g of wet algal biomass. Binding of the recombinant protein to the affinity resin 
was performed for 2 h at 4 ºC by continuous end-over-end mixing in a Glass Col rotor at 
~ 33 rpm (40 % speed control).  Affinity resin was washed with 10 column volumes 
(CV) of lysis buffer followed by 3 column volume of lysis buffer without Tween.  The 
washed FLAG resin was transferred into Bio Spin disposable chromatography columns 
(Bio Rad, Cat # 732-6008) for protein elution at room temperature.  Recombinant 
protein was eluted at pH 3.5 using 5 CV of 100 mM glycine buffer, pH 3.5 that 
contained 400 mM NaCl.  Eluted protein fractions were collected in 5 tubes containing a 
predetermined amount of 1M Tris-HCl, pH 8.0 to immediately increase the pH of eluted 
protein to pH 8.0 and avoid protein denaturation.  Typically, three elution fractions (E2 
 49 
 
to E4) were used for estimation of purity and yield, although some losses were occurring 
by not taking into account E1 (Elution fraction 1).  By pooling these three fractions, 
more than 80% of extracted FLAG-tagged proteins were recovered.  Extraction buffer 
and all the materials used including the sonication probe (1/8’ microtip A3-561 
BRANSON, USA) were cooled in advance. 
The FLAG affinity purification method was used as a convenient analytical tool 
to determine the recombinant extraction yield.  The resin was added in sufficient 
amounts to bind all available FLAG fusion protein present in clarified extracts.  Cell 
debris and supernatants at the end of the batch adsorption period were regularly analyzed 
by western blotting to assure complete extraction and adsorption, respectively.  Although 
minor recombinant protein losses have occurred during resin washing and pH 3.5 elution 
from the anti-FLAG resin, this determination of recombinant protein concentration was 
considered appropriate for estimating recombinant protein in crude extracts. 
 
3.2.7. DNA determination 
The DNA concentration in the algae extract subjected to different extraction 
conditions was determined using a Quant-iT™ PicoGreen ® dsDNA Reagent Kit from 
Molecular Probes (Eugene, OR). The assay was performed using a fluorescence plate 
reader, Spectra Max Gemini XS, from Molecular Devices following the procedure 
recommended by the manufacturer. The samples were excited at 480 nm, and the 
fluorescent emission intensity at 520 nm was measured. The assay limit is 250 pg/mL. 
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Standard curve (Range 1-1000 ng/ml) was made using lamda DNA standard present in 
the kit. 
 
3.2.8. Chlorophyll determination 
Chlorophyll (a and b) was measured by measuring the optical density at 652 nm 
wavelength using a Beckman Coulter (Brea, CA) DU640 spectrophotometer. Lysis 
buffer (with/without ammonium sulfate; chitosan) was used as blank. 
 
3.2.9. Turbidity measurement 
It was measured by measuring the optical density at 750 nm wavelength using a 
Beckman Coulter (Brea, CA) DU640 spectrophotometer. Lysis buffer (with/without 
ammonium sulfate; chitosan) was used as blank. 
 
3.2.10. Statistical analysis 
Design Expert software was used for the experimental design and analysis. The 
statistical significance of the models was evaluated by the analysis of variance 
(ANOVA). Effects with more than 95% of significance (95% confidence interval) that 
is, effects with a p-value lower than 0.05 were significant. Significantly different means 
(P < 0.05) were separated by the Tukey’s test. 
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3.3. Results and Discussion 
 
3.3.1. Extraction optimization of αCD22 scFv 
Previously, we have established that the optimization of algal growth and 
induced-expression conditions could significantly enhance recombinant protein 
concentration per gram wet algal biomass [111].  Another way to further enrich algae 
extracts in recombinant protein concentration is to examine the effect of key extraction 
variables on recombinant protein yield and the concentration of host cell impurities. A 23 
full factorial design was performed to determine the effect of salt NaCl, detergent Tween 
20, and pH on culture concentration of recombinant protein αCD22 scFv. A biomass-to-
buffer ratio of 1:5 (instead of 1:10) was used to reduce the process volume without 
compromising the amount of extracted recombinant protein.  Table 2 compares the effect 
of different extraction conditions on the concentration of chlorophyll, host cell protein, 
DNA, and αCD22 scFv in clarified extracts.  Each factor was studied on two levels: pH 
(4.5 and 8), NaCl (100 mM and 400 mM) and Tween (0% and 0.5%). Based on previous 
extraction data of recombinant proteins from transgenic plant tissues and algae [5, 6, 69, 
105], the specific levels of all three factors were chosen. The concentrations of measured 
impurities and recombinant protein were normalized against those obtained at pH 8.0, 
0.4 M NaCl, and 0.5% Tween.  At pH 8, both Tween and 400 mM salt were required for 
maximum extraction of αCD22 scFv. Omitting Tween from the extraction buffer 
reduced the concentration of both αCD22 scFv and HCP by 29% and 22%, respectively. 
Chlorophyll concentration at pH 8 was affected (25% reduction) only when Tween was 
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removed from the buffer and salt concentration reduced to 100 mM.  The latter two 
concentrations further reduced the extracted HCP and αCD22 scFv by about 20%.  DNA 
concentration at pH 8 was not affected by any of tested variables. DNA concentration 
was significantly reduced (by 40 %) only at pH 4.5 with no Tween and 100 mM salt. 
αCD22 scFv concentration remained at about 70% for all pH 4.5 tested conditions. At 
pH 4.5, Tween alone had a pronounced effect on extracted chlorophyll at both salt 
concentrations, reduction by 45% and 60%.  HCP was reduced from 62% to 22% in the 
absence of Tween if pH 4.5 buffer contained 400 mM salt. It was thus observed that 
buffer of high pH with high salt and Tween maximize host cell protein extraction, 
whereas pH 4.5 and low or no salt in the extraction buffer results in minimum amount of 
host cell proteins. In conclusion, a combination of low pH buffer, low ionic strength 
(low salt concentration) and absence of Tween in the lysis buffer could significantly 
reduce chlorophyll (70%) and total soluble protein (55%) concentrations; unfortunately, 
under those conditions a loss of 30% αCD22 scFv was also observed.  Chloroplast 
expressed proteins may  require detergents Tween to reduce hydrophobic interaction 
with thylakoid membranes similarly to recombinant proteins expressed in tobacco 
chloroplast [70, 71], but this effect has been observed at pH 8 and not pH 4.5.  Our data 
suggest that the recovery of chloroplast-expressed protein is somewhat related to the 
solubilization of host-cell protein and probably to reduction of hydrophobic protein-
protein and protean–membrane interactions. The maximum recovery yield of αCD22 
scFv was achieved at pH 8 with 400 mM salt and 0.5% Tween, the conditions that also 
maximize HCP, DNA, and chlorophyll extractability.  Adjusting the pH of the algae 
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lysate to <5.0 reduces solubility of most abundant protein (RubisCo), which has a pI of 
5.2 and indirectly chlorophyll pigments attached to host cell protein.  The addition of 
Tween at pH 4.5 increased chlorophyll solubility and host cell protein, but did not result 
in measureable change of αCD22 scFv. The extraction data suggest that pH 4.5, 100 
mM, and no Tween conditions are optimal with respect to extract impurities and 
potentially interesting if 70% αCD22 scFv extraction yield would be acceptable.  
 
Table 2. Effect of extraction conditions (pH, NaCl, Tween) on normalized 
concentrations of chlorophyll, HCP, αCD22 scFv and DNA. Values given are averages 
from 3 replicates. a,b For each observation, means within a column which are not 
followed by a common superscript letter are significantly different (P < 0.05). x Standard 
deviation. 
Extraction 
conditions 
Criteria studied 
pH, NaCl 
(mM),Tween 
% 
Chlorophyll 
(%) 
HCP 
(%) 
αCD22 scFv 
(%) 
DNA 
(%) 
8, 400, 0.5 100 a ± 6.7 x 100 a ± 13.4 100 a ± 14.6 100 a ± 10.4 
8, 400, 0 98.3 a ± 0.5 78.3 b ±16.3 70.9 b ± 1.9 115.5 a ± 2.2 
8, 100, 0.5 95.8 a ± 3.9 103 a ± 4.0 52.4 b ± 19.5 105.9 a ± 8.7 
8, 100, 0 75 b ± 3.5 56 b ± 15.5 62.5 b ± 15.6 135 a ± 18.1 
4.5, 400, 0.5 73.5 b ± 4.9 61.5 b ± 9.9 62 b ± 24 128.3 a ± 25 
4.5, 400, 0 28.5 c ± 2 21.6 c ± 8.3 74 b ± 4.2 92.2 a ± 8.3 
4.5, 100, 0.5 77.8 b ± 4 50 b ± 15.3 70 b ± 21.2 98.2 a ± 7.2 
4.5, 100, 0 17.9 d ± 0.9 45.7 b ± 0.9 71.1 b ± 5.5 61.9 b ± 4.2 
 
 
 54 
 
3.3.2. Evaluation of different primary recovery methods 
Optimum extraction conditions that are critical for maximum product recovery 
are often optimal for the release of a variety of host cell proteins and other water soluble 
cell components such as DNA, chlorophyll pigments, polysaccharides, and proteases.  
Since these components can affect the final product quality and reduce purification it is 
important to condition and pre-treat the extract before further purification. After 
homogenization, the cell lysate is commonly subjected to solid-liquid separation by 
centrifugation to remove the cell debris and insoluble impurities to form cell-free extract 
(Figure 7).  As shown in Figure 7, pretreatment methods can be implemented either on 
cell-free extract or directly on the cell lysate. Direct pretreatment of cell lysate, 
whenever possible, is desirable because a single centrifugation step could be used to 
remove cell derris and other precipitated or flocculated lysate impurities.  The choice to 
pretreat cell lysate or cell-free extracts will made by determining  recombinant protein 
yield after selected pretreatment and overall pretreatment efficacy i.e. removal of 
undesirable impurities by the end of primary recovery process (Figure 7).   
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Figure 7. Primary recovery steps of αCD22 scFv from C. reinhardtii lysate. 
 
After homogenization of C. reinhardtii cells in the optimum extraction buffer, 
different pretreatments were evaluated for clarification of algae extract from cell-free 
extract and cell lysate. The choice of these pretreatment methods mainly depended on 
factors like compatibility of the method with further affinity purification steps, product 
quality and yield and reduction of overall impurity burden. Different primary recovery 
methods evaluated were ammonium sulfate precipitation, acidic precipitation, and 
polymer precipitation. 
The preliminary screening of different concentration of ammonium sulfate was 
done to obtain maximum reduction of host cell protein and chlorophyll in the algae 
extract. The plotting trend in Figure 8 shows the effect ammonium sulfate concentration 
on host cell protein and chlorophyll remaining in the algae extract after precipitation. It 
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was observed that increasing the concentration of ammonium sulfate in the algae extract 
resulted in more reduction of proteins and chlorophyll in the supernatant after 
precipitation. Ammonium sulfate concentration of (1 M) or more had a notable effect on 
the reduction of host cell protein and chlorophyll in the extract. A proportional decrease 
in the chlorophyll pigments can be attributed to pigments attachment to precipitated 
proteins. By following a conservative approach to prevent the loss of the recombinant 
protein in the pellet, 1M concentration was chosen for further study. Also, with higher 
saturation there is a possibility of interference from ammonium sulfate in subsequent 
affinity chromatography. 
 
 
Figure 8. Effect of ammonium sulfate concentration on residual host cell protein 
(HCP)and chlorophyll in supernatants after precipitation. Values plotted are averages 
from 3 replicates; bars represent standard deviation. 
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The effect of different primary recovery methods on the conditioning of algae 
extract is summarized in Table 3 and Table 4. Ammonium sulfate precipitation and 
acidic precipitation was done on cell-free extract and cell lysate, whereas polymer 
precipitation with chitosan at pH 5 was done on cell lysate. The clarification of algae 
extract after each pretreatment was evaluated by quantification of impurities, namely 
DNA, chlorophyll pigments, host cell proteins, aggregates (turbidity) and recovery 
percentage of target recombinant protein αCD22 scFv measured by anti-FLAG affinity 
chromatography. Control experiment (no pretreatment) was performed from the same 
algae batch to minimize the effect of batch-to-batch variability.  Each criterion was 
compared and normalized to the respective concentrations obtained with the control. In 
comparison to the control, the host cell protein of the pretreated extracts (acidic 
precipitation and ammonium sulfate precipitation) of both cell-free lysates and cell 
lysates was reduced to a large extent (31%-57%), but did not vary significantly with the 
pretreatment type, i.e. acid vs. salt precipitation. In contrast, the chlorophyll content 
showed a wide range among the pretreatment tested and was  reduced  by 30% (cell-free 
lysate) to 70% (cell lysate) in ammonium sulfate precipitation and 72% (cell-free lysate) 
to 45% (cell lysate) in case of acidic precipitation. However, both the pretreatments 
failed to reduce the DNA content. In both, ammonium sulfate precipitation and acidic 
precipitation, it is evident that there is a significant difference in the yield of αCD22 
scFv and chlorophyll between cell-free extract and cell lysate. When cell free extract 
was subjected to acidic precipitation, a αCD22 scFv yield of 118.8% ± 21.8 was 
reported, compared to a yield of 87.5% ± 5.06 in case of ammonium sulfate 
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precipitation. The yield of αCD22 scFv from pretreated cell-free extracts was 
significantly different from that obtained from pretreated cell lysates (73.12% ± 10.9 for 
acidic and 79.8% ± 10.9 for ammonium sulfate). In the experiments with cell lysates, 
αCD22 scFv losses ranged from about 20% to 27%.  If the given losses are acceptable, 
the flexibility of operating the two pretreatment methods (acidic precipitation and 
ammonium sulfate precipitation) on cell lysate would be more economical as it allows 
cell debris removal and impurity reduction simultaneously with only one centrifugation 
step. 
An interesting observation was made when we compared acidic precipitation at 
pH 4.5 of cell lysate (50 mM Tris, 400 mM NaCl, 0.5% Tween) with the extraction at 
pH 4.5 in 50 mM Tris, 400 mM NaCl, 0.5% Tween. In the former, there was a reduction 
in αCD22 scFv yield by about 27%, whereas during the extraction under the same 
conditions we observed a significantly greater loss of 38%, probably due to the lower 
solubility of acidic host proteins.  The reduction αCD22 scFv extraction yield by 38% 
was the similar to that of HCP (39%). 
In contrast to acidic and ammonium sulfate precipitation, the lysate pretreatment 
with chitosan at pH 5 proved to be a better method in terms of impurities reduction in the 
algae extract (Table 4).  It not only reduced the chlorophyll (58%) and protein (82%), 
but chitosan was able to flocculate the cell debris making their removal with low speed 
centrifugation possible. Most importantly, there was a significant reduction in DNA 
content to 14%, resulting in a less viscous and easier to filter extracts.  However, the 
polymer pretreatment methods led to a 35% loss of αCD22 scFv, when compared to the 
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control. This loss is relatively high for a primary recovery steps, but because of the other 
benefits further optimization of this pretreatment method is probably warranted.  
 
Table 3. Effect of pretreatment method of cell-free extract on residual DNA, 
chlorophyll, host cell protein, and αCD22 scFv yield in algae extract. Values given are 
averages from 3 replicates ± standard deviations. a,b,c For each observation, means which 
do not share a common superscript letter are significantly different from the control no 
pretreatment (P < 0.05). 
 
Residual 
DNA (%) 
Residual 
Chlorophyll 
(%) 
Residual 
Host Cell 
Protein (%) 
αCD22 scFv 
yield (%) 
No Pretreatment 100a ± 9.12 100a ± 4.8 100a ± 14.5 100a ± 16.3 
Ammonium sulfate 
precipitation at pH 8 
100a  ± 1.3 60.1b  ± 6.3 56.7b ± 6.7 87.5a ± 5.06 
Acidic precipitation 
at pH=4.5 
91.7a ± 7.6 28.4c ± 14.7 31.1c ± 9.3 118.8a ± 21.8 
 
Table 4. Effect of pretreatment method of cell lysate on residual DNA, chlorophyll, host 
cell protein, and αCD22 scFv yield in algae extract. Values given are averages from 3 
replicates ± standard deviations. a,b,c For each observation, means which do not share a 
common superscript letter are significantly different from the control (P < 0.05). 
 
Residual 
DNA (%) 
Residual 
Chlorophyll 
(%) 
Residual 
Host Cell 
Protein (%) 
αCD22 scFv 
yield (%) 
 
No Pretreatment 100a ± 9.12 100a ± 4.8 100a ± 14.5 100a ± 16.3 
Ammonium sulfate 
precipitation at pH 8 
100a ± 0.1 31.5b ± 8.2 46.1b ± 7.4 79.8b ± 10.9 
Acidic precipitation at 
pH=4.5 
92.6a ± 
10.5 
55c ± 1.6 36.1b ± 1.6 
73.12bc ± 
10.9 
Chitosan precipitation 
at pH=5.0 
14b ± 1.41 
 
42.4b ± 0.2 
 
17.7c ± 4.9 
 
65.3c ± 1.72 
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All three pretreatment methods were able to decrease turbidity of centrifuged 
extracts (Figure 9). Ammonium sulfate and acidic precipitation methods decreased 
turbidity of lysates and cell-free extracts from 0.49 ± 0.08 to 0.15 ± 0.03 and 0.27 ± 0.11, 
respectively.  The chitosan-mediated pretreatment resulted in more than tenfold decrease 
in extract turbidity. Lower viscosity of chitosan treated extracts along with the 
significant decrease in turbidity (OD750 = 0.04) affected 0.45 µm filtration efficiency 
significantly.  We have observed a threefold increase in filtration throughput (processed 
volume / area) with chitosan pretreatment, compared to 1.5 fold each with ammonium 
sulfate and acidic precipitation. 
 
 
Figure 9. Effect of different pretreatment methods on turbidity (O.D.750) of algae extract 
after centrifugation and before 0.45 µm filtration. Values plotted are averages from 3 
replicates (bars are standard deviations). 
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All pretreatment methods tested in this work have pros and cons, which depend 
on the target protein to be purified and compatibility with potential capture (first 
purification) methods. For instance, if polymer flocculation is being considered for 
clarification, diligent consideration must be made to verify the impact of polymer on the 
binding capacity of affinity chromatography as well as ensuring removal of the 
flocculating agents to acceptable levels in the drug product. For ion exchange capture 
step, it is preferable not to alter the ionic strength of the extract during pretreatment to 
avoid the conductivity adjustment by dilution or diafiltration before loading onto the 
capture column. Thus, prior to ion exchange chromatography, a salt induced precipitated 
extract will likely require dilution or diafiltration step. For example, incase of 
clarification of rice cell suspension containing HSA, dialysis was done after 40% 
ammonium sulfate precipitation prior to loading on anion exchange column [76]. 
Alternatively, to skip the dilution or removal of ammonium sulfate from clarified 
extracts after the precipitation step, one could choose to use hydrophobic interaction 
chromatography as a capture step, as in case of tobacco cell suspension extract 
containing GFP-fusion protein [75]. After acidic precipitation, additional pH adjustment 
of the extract may be required for efficient binding of the target protein to an affinity, ion 
exchange, or HIC resin. Acidic precipitation, otherwise, does not significantly alter 
extract conductivity. Also, the pH and net protein charge dictates the selection between 
anion and cation exchange chromatography. Thus, pretreatment methods should be 
chosen on a case-by-case basis and modified accordingly. The testing of these primary 
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recovery methods on microalgae C. reinhardtii extracts certainly lays down a road map 
for further downstream processing testing for algae platform. 
 
3.3.3. Analysis of pretreated extracts by FLAG affinity chromatography 
After being subjected to different extraction and primary recovery method, 
recombinant protein was purified from clarified crude lysates by FLAG affinity 
adsorption and analyzed by Western blotting. In each experimental study, αCD22 scFv 
protein purified from filtered algae extract (from the same batch) without pretreatment 
was used as control. 
Figure 10 demonstrates the comparison of the eluted fractions of αCD22 scFv 
purified from ammonium sulfate treated cell-free algae extract vs. no pretreatment. The 
presence of bands of negligible intensity in the supernatant after 2 hours of incubation 
(lane 7) at the same size as αCD22 scFv (30 kDa) confirm the efficient binding of 
FLAG-tagged αCD22 scFv  to the anti-FLAG affinity resin in presence of ammonium 
sulfate. In both control and pretreated extracts, total eluted protein analysis by Bradford, 
indicated that the majority of purified αCD22 scFv (30 kDa band) eluted in fractions 2, 3 
and 4 (lanes 2,3 and 4; lanes 8, 9 and 10).  These three fractions typically contained 
approximately 80% of the total eluted recombinant protein from the resin. Western blot 
revealed the presence of minor degradation products of 14 and 17 kDa in size. The 
analyses of purified αCD22 scFv from pretreated extracts (lanes 8, 9 and 10) revealed no 
significant deviation in quality compared to the eluted fractions (lanes 2, 3 and 4) from 
control (no pretreatment) extract. Thus, ammonium sulfate precipitation did not affect 
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the further downstream affinity chromatography or the quality and yield of αCD22 scFv 
(87.5 % ± 5.06 for cell-free extract) adversely. However, further analysis is required to 
confirm the same. 
 
 
Figure 10. Comparison of Western blot analysis (using anti-FLAG-AP conjugated 
antibody) of C. reinhardtii αCD22 scFv purified from cell-free extract treated with 
ammonium sulfate precipitation vs. no pretreatment control. Lane 1: clarified initial 
extract (no pretreatment); Lanes 2 to 4: pH 3.5 eluted fractions (no pretreatment); Lane 
5: molecular weight marker (kDa); Lane 6: clarified initial extract after ammonium 
sulfate precipitation (1.5 times diluted); Lane 7: 1.5 times diluted supernatant after 2 h of 
binding with anti-FLAG resin (ammonium sulfate precipitation); Lanes 8 to 10: pH 3.5 
eluted fractions (ammonium sulfate precipitation). 
 
The comparison of the eluted fractions of αCD22 scFv purified from acidic 
precipitation treated cell-free extract with no pretreatment is shown in Figure 11. The 
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analyses of purified αCD22 scFv from pretreated extracts (lanes 1, 3, 4 and 5) revealed 
no significant degradation when compared to the eluted fractions (lanes 7, 8, 9 and 10) 
from control (no pretreatment) extract. αCD22 scFv seems to remain stable at low pH 
for a limited amount of time tested. However, further analysis is required to confirm the 
same. 
 
 
Figure 11. Comparison of Western blot analysis (using anti-FLAG-AP conjugated 
antibody) of C. reinhardtii αCD22 scFv purified from cell-free extract treated with 
acidic precipitation vs. no pretreatment control. Lane 1: clarified initial extract after 
acidic precipitation; Lane 2: Supernatant after 2 h of binding with anti-FLAG resin 
(acidic precipitation); Lane 3 to 5: pH 3.5 eluted fractions (acidic precipitation); Lane 6: 
molecular weight marker (kDa); Lane 7: clarified initial extract (no pretreatment); Lanes 
8 to 10: pH 3.5 eluted fractions (no pretreatment). 
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As discussed above, with chitosan precipitation at pH 5, we were able to reduce 
most of the impurities including DNA, proteins, chlorophyll and debris. However, we 
also observed a significant loss (35%) of the target protein, αCD22 scFv. This was also 
prevalent in the western blot analysis (Figure 12) of eluted fractions and supernatant 
after 2 h of binding with Anti FLAG resin (chitosan precipitation). In case of chitosan 
precipitation, there was a high intensity band of 30 kDa in the supernatant after 2 h of 
binding to anti-FLAG affinity resin, suggesting possible interference with binding of 
FLAG tagged recombinant protein to the anti-FLAG resin in presence of chitosan. 
However, a slight band of 30kDa was also observed in supernatant of no pretreatment 
(lane 2) suggesting inefficient binding with anti-FLAG resin. The results are thus 
inconclusive. Polymer precipitation is promising but it needs further optimization to 
prevent loss of αCD22 scFv. 
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Figure 12. Comparison of Western blot analysis (using anti-FLAG-AP conjugated 
antibody) of C. reinhardtii αCD22 scFv purified from cell lysate treated with chitosan 
precipitation vs. no pretreatment control. Lane 1: clarified initial extract (no pretreatment 
control); Lane 2: supernatant after 2 h of binding with anti-FLAG resin (no pretreatment 
control); Lanes 3 to 5: pH 3.5 eluted fractions (no pretreatment); Lane 6: clarified initial 
extract after chitosan precipitation (1.6 times diluted); Lane 7: 1.5 times diluted 
supernatant after 2 h of binding with anti-FLAG resin (chitosan precipitation); Lanes 8 
to 10: pH 3.5 eluted fractions (chitosan precipitation). 
 
3.4. Summary 
 
This study investigated the process variables affecting extraction and recovery of 
recombinant protein in the algae extract. Composition of extraction buffer was optimized 
based on three factors - pH, NaCl (mM) and Tween. The maximum recovery yield of 
αCD22 scFv was achieved at pH 8 with 400 mM salt and 0.5% Tween, the conditions 
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that also maximize host cell protein (HCP), DNA, and chlorophyll extractability. A 
combination of low pH buffer, low ionic strength (low salt concentration) and absence of 
Tween in the lysis buffer could significantly reduce chlorophyll (~70%) and total soluble 
protein (~55%) concentrations; unfortunately, under those conditions a loss of ~30% 
αCD22 scFv was also observed. In conclusion, along with pH 8, high salt and Tween 20 
are required for maximum recovery of chloroplast expressed αCD22 scFv. 
It has been identified that a relatively inexpensive upstream protein production 
platform like by C. reinhardtii has to be matched by low cost downstream processing. 
Investigation of different primary recovery methods, viz., ammonium sulfate 
precipitation, acidic precipitation and cationic polymer (chitosan) precipitation on cell-
free extract as well as cell lysate of C. renihardtii, revealed interesting insights. It was 
interesting to note that both ammonium sulfate precipitation and acidic precipitation 
performed well with cell-free extract as almost all αCD22 scFv was recovered compared 
to control with a significant reduction of chlorophyll and HCP. However, with cell 
lysates, both acidic precipitation and ammonium sulfate precipitation reported a loss of 
αCD22 scFv by 27% and 20% respectively. Polymer precipitation with chitosan at pH 5 
on cell lysate was successful not only in reducing HCP (82%), chlorophyll (58%),  
debris, but also in remarkably reducing the DNA (hence turbidity) (14%) and turbidity 
of the algae extract compared to the control. Consequently, this resulted in better 
filterability of the extract. However, a notable loss of 35% αCD22 scFv was observed 
with chitosan precipitation. Thus, although polymer precipitation is promising, it needs 
further optimization to prevent the loss of the target protein. 
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All the three methods with cell lysate resulted in similar loss of αCD22 scFv 
yield (~30%). The mechanism of precipitation with the three agents is different. Also, 
extraction in lysis buffer of pH 4.5 resulted in a αCD22 scFv loss of 38%. This suggests 
entrapment of αCD22 scFv by precipitated proteins and chitosan formed flocs. It is 
likely that the target protein gets entrapped in the cell debris while precipitation, 
resulting in the loss of yield. 
According to the western blot analysis, none of the pretreatments altered the 
quality of the target protein αCD22 scFv. However, further analysis by size exclusion 
chromatography is required to confirm the same. The selection of these pretreatments for 
conditioning of algae extract depends on case by case basis. The pretreatment can be 
selected based on its compatibility with the first downstream purification step or the best 
pretreatment for a particular target product can guide the selection of the first 
downstream processing step. 
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CHAPTER IV 
CONCLUSIONS AND RECOMMENDATIONS 
 
4.1. Conclusions 
 
Chlamydomonas reinhardtii chloroplast has a demonstrated potential for 
producing complex recombinant proteins. This study attempted to investigate the process 
variables affecting the growth of the microalgae, accumulation and recovery of 
recombinant protein αCD22 scFv and impurities. This has added to the current scientific 
knowledge on ‘microalgae as biofactories’ and will assist in making this platform 
commercially attractive. The major challenges identified during this study were, i) low 
transgene expression level, and ii) resin or membrane fouling due to presence of 
impurities like host cell proteins, DNA, chlorophyll and other pigments. 
The problem of low recombinant protein was addressed in first part of the 
investigation (Chapter II) by optimization the algal cultivation and light inducible 
accumulation of αCD22 scFv protein. Maximum biomass accumulation of transgenic C. 
reinhardtii was achieved after resuspending the cells in fresh TAP media after five days 
of heterotrophic growth. Consequently, a 2.8-fold increase in the culture concentration 
of recombinant therapeutic proteins αCD22 scFv and Pfs25 was observed, but this could 
also be achieved by adding acetate.   
The psbA regulated expression of αCD22 scFv protein in the chloroplast was 
also significantly affected by light duration and intensity. The exposure of light of 300 
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μmol m−2 s−1 for 24 h resulted in a maximum culture concentration of αCD22 scFv 
(314.0 ± 20 μg/mL), which is a two-fold increase compared to 101 μmol m−2 s−1. Thus, 
an increase in light intensity to 300 μmol m−2 s−1 not only increased the recombinant 
protein production, but also led to an efficient product recovery with a two-fold increase 
of the recombinant protein fraction in the extracted soluble protein. Overall, 
resuspension and light optimization resulted in a six-fold increase in the recovered 
recombinant protein in the chloroplasts of C. reinhardtii. 
The second challenge was dealt in Chapter III. This study investigated the 
process variables affecting extraction and recovery of recombinant protein and 
impurities in the algae extract. The maximum recovery yield of αCD22 scFv was 
achieved at pH 8 with 400 mM salt and 0.5% Tween, the conditions that also maximize 
host cell protein (HCP), DNA, and chlorophyll extractability. A combination of low pH 
buffer, low ionic strength (low salt concentration) and absence of Tween in the lysis 
buffer could significantly reduce chlorophyll (70%) and total soluble protein (55%) 
concentrations; unfortunately, under those conditions a loss of 30% αCD22 scFv was 
also observed.  
On cell-free extract the two pretreatments (ammonium sulfate precipitation and 
acidic precipitation) were efficient in reducing chlorophyll and HCP and recovering 
almost all αCD22 scFv, compared to the control. However, with cell lysates, both acidic 
precipitation and ammonium sulfate precipitation reported a loss of αCD22 scFv by 27% 
and 20% respectively. Polymer precipitation with chitosan at pH 5 on cell lysate was 
promising as it not only resulted in the reducing HCP (82%), chlorophyll (58%), debris, 
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but also in remarkably reducing the DNA (14%) and turbidity of the algae extract 
compared to the control and hence resulting in better filterability of the extract. 
However, a notable loss of 35% αCD22 scFv was observed with chitosan precipitation. 
Thus, it needs further optimization to prevent the loss of the target protein. All the three 
methods with cell lysate resulted in similar loss of αCD22 scFv yield (~30%) probably 
due to entrapment of αCD22scFv in the precipitated proteins and cell debris. 
As analyzed by western blots, none of the pretreatments altered the quality of the 
target protein αCD22 scFv. However, further analysis by size exclusion chromatography 
is required to confirm the same. The selection of these pretreatments for conditioning of 
algae extract depends on case by case basis. The pretreatment can be selected based on 
its compatibility with the first downstream purification step or the best pretreatment for a 
particular target product can guide the selection of the first downstream processing step. 
In both studies, FLAG affinity adsorption was used as an analytical technique for 
purification and recovery of the recombinant proteins. However, anti-FLAG affinity 
resin is not sufficiently robust for column scale up. Therefore, other affinity tags or 
chromatography techniques should be considered to enable robust process purification 
scale up. 
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1. To investigate the effect of light-dark cycle on the growth of C. reinhardtii and 
accumulation of αCD22 scFv. 
2. To further optimize chitosan precipitation with an aim to reduce the loss of αCD22 
scFv. 
3. To screen different polymers for flocculation of cell debris and reduction of 
impurities. 
4. To screen different affinity and non affinity resins for capture of αCD22 scFv and 
develop purification process to achieve more than 90% purity. 
5. To evaluate the compatibility of different pretreatment methods with the first 
purification chromatography method. 
4.2. Recommendations 
 
The suggestions for future work include: 
 73 
 
REFERENCES 
 
1. Leader, B.; Baca, Q.J.; Golan, D.E. Protein therapeutics: a summary and 
pharmacological classification. Nat Rev Drug Discov, 2008. 7(1): p. 21-29. 
 
2. Mayfield, S. P.; Franklin, S. E.; Lerner, R. A. Expression and assembly of a fully 
active antibody in algae. Proc Natl Acad Sci USA, 2003. 100(2): p. 438-442. 
 
3. Mayfield, S. P.; Franklin, S. E. Expression of human antibodies in eukaryotic 
micro-algae. Vaccine, 2005. 23(15): p. 1828-1832. 
 
4. Mayfield, S. P.; Manuell, A.L.; Chen, S.; Wu, J.; Tran, M.; Siefker, D.; Muto, 
M.; Navarro, J.M. Chlamydomonas reinhardtii chloroplasts as protein factories. 
Curr Opin Biotechnol, 2007. 18(2): p. 126-133. 
 
5. Gregory, J.A.; Li, F.; Tomosada, L.M.; Cox, C.J.; Topol, A.B.; Vinetz, J.M.; 
Mayfield, S.P. Algae-produced Pfs25 elicits antibodies that inhibit malaria 
transmission. PLoS ONE, 2012. 7(5): p. e37179. 
 
6. Tran, M.; Van, C.; Barrera, D.J.; Pettersson, P.L.; Peinado, C.D.; Bui, J.; 
Mayfield, S.P. Production of unique immunotoxin cancer therapeutics in algal 
chloroplasts. Proc Natl Acad Sci, 2012. 110(1): p. 15-22. 
 
7. Dove, A. Uncorking the biomanufacturing bottleneck. Nat Biotechnol, 2002. 
20(8): p. 777-779. 
 
8. Adamson, S.R. Experiences of virus, retrovirus and retrovirus-like particles in 
Chinese hamster ovary (CHO) and hybridoma cells used for production of 
protein therapeutics. Dev Biol Stand, 1998. 93: p. 89-96. 
 
9. Baneyx, F.; Mujacic, M. Recombinant protein folding and misfolding in 
Escherichia coli. Nat Biotechnol, 2004. 22(11): p. 1399–1408. 
 
10. Cereghino, G.P.; Cregg, J.M. Applications of yeast in biotechnology: protein 
production and genetic analysis. Curr Opin Biotechnol, 1999. 10(5): p. 422-427. 
 
11. Twyman, R. M.; Stoger, E.; Schillberg, S.; Christou, P.; Fischer, R. Molecular 
farming in plants: host systems and expression technology. Trends Biotechnol, 
2003. 21(12): p. 570-578. 
 
 74 
 
12. Twyman, R.M. Host plants, systems and expression strategies for molecular 
farming, in Molecular farming: Plant-made pharmaceuticals and technical 
proteins, ed. S.Schillberg & R. Fischer. 2004, Weinheim, Germany: Wiley-VCH. 
 
13. Doran, P. M. Foreign protein production in plant tissue cultures. Curr Opin 
Biotechnol, 2000. 11(2): p. 199-204. 
 
14. Paul, M.; Ma, J.K. Plant-made immunogens and effective delivery strategies. 
Expert Rev Vaccines, 2010. 9(8): p. 821-33. 
 
15. Kreitman, R. J. Recombinant immunotoxins containing truncated bacterial toxins 
for the treatment of hematologic malignancies. BioDrugs, 2009. 23(1): p. 1-13. 
 
16. Rasala, B.A.; Muto, M.; Lee, P.A.; Jager, M.; Cardoso, R.M.F.; Behnke, C.A.; 
Kirk, P.; Hokanson, C.A.; Crea, R.; Mendez, M.; Mayfield, S.P. Production of 
therapeutic proteins in algae, analysis of expression of seven human proteins in 
the chloroplast of Chlamydomonas reinhardtii. Plant Biotechnol J, 2010. 8(6): p. 
719-733. 
 
17. Lee do, Y.; Fiehn, O. High quality metabolomic data for Chlamydomonas 
reinhardtii. Plant Methods, 2008. 4: p. 7. 
 
18. Harris, E. H. Chlamydomonas Sourcebook Introduction to Chlamydomonas and 
its Laboratory Use. 2009, New York Academic Press Inc.  
 
19. Manuell, A.L.; Beligni, M.V.; Elder, J.H.; Siefker, D.T.; Tran, M.; Weber, A.; 
McDonald, T.L.; Mayfield, S.P. Robust expression of a bioactive mammalian 
protein in Chlamydomonas chloroplast. Plant Biotechnol J, 2007. 5(3): p. 402–
412. 
 
20. Mayfield, S. P.; Manuell, A. L.; Chen, S.; Wu, J.; Tran, M.; Siefker, D.; Muto, 
M.; Marin-Navarro, J. Chlamydomonas reinhardtii chloroplasts as protein 
factories. Curr Opin Biotechnol, 2007. 18(2): p. 126-133. 
 
21. Tran, M.; Henry, R.E.; Siefker, D.; Van, C.; Newkirk, G.; Kim, J.; Bui, J.; 
Mayfield, S.P. Production of anti-cancer immunotoxins in algae: Ribosome 
inactivating proteins as fusion partners. Biotechnology and Bioengineering, 
2013. 110(11): p. 2826–2835. 
 
22. Tran, M.; Zhou, B.; Pettersson, P.L.; Gonzalez, M.J.; Mayfield, S.P. Synthesis 
and assembly of a full-length human monoclonal antibody in algal chloroplasts. 
Biotechnol Bioeng, 2009. 104(4): p. 663-673. 
 
 75 
 
23. Surzycki, R.; Greenham, K.; Kitayama, K.; Dibal, F.; Wagner, R.; Rochaix, J.D.; 
Ajam, T.; Surzycki, S. Factors effecting expression of vaccines in microalgae. 
Biologicals, 2009. 37(3): p. 133-138. 
 
24. Holliger, P.; Hudson, P.J. Engineered antibody fragments and the rise of single 
domains. Nat Biotechnol, 2005. 23(9): p. 1126–1136. 
 
25. Nelson, A.L. Antibody fragments: Hope and hype. MAbs, 2010. 2(1): p. 77–83. 
 
26. Nelson, A.L.; Reichert, J.M. Development trends for therapeutic antibody 
fragments. Nat Biotechnol, 2009. 27: p. 331–337. 
 
27. Maynard, J.; Georgiou, G. Antibody engineering. Annu Rev Biomed Eng, 2000. 
2: p. 339-376. 
 
28. Whitlow, M.; Bell, B.A.; Feng, S.L.; Filpula, D.; Hardman, K.D.; Hubert, S.L.; 
Rollence, M.L.; Wood, J.F.; Schott, M.E.; Milenic, D.E.; et al. An improved 
linker for single-chain Fv with reduced aggregation and enhanced proteolytic 
stability. Protein Eng, 1993. 6(8): p. 989–995. 
 
29. Alfthan, K.; Takkinen, K.; Sizmann, D.; Soderlund, H.; Teeri, T.T. Properties of 
a single-chain antibody containing different linker peptides. Protein Eng, 1995. 
8(7): p. 725–731. 
 
30. Monnier, P.P.; Vigouroux, R.J.; Tassew, N.G. In Vivo Applications of Single 
Chain Fv (Variable Domain) (scFv) Fragments. Antibodies, 2013. 2(2): p. 193-
208. 
 
31. Hudson, P.J. Recombinant antibody fragments. Curr Opin Biotechnol, 1998. 
9(4): p. 395–402. 
 
32. Chowdhury, P.S.; Viner, J.L.; Beers, R.; Pastan, I. Isolation of a high-affinity 
stable single-chain Fv specific for mesothelin from DNA-immunized mice by 
phage display and construction of a recombinant immunotoxin with anti-tumor 
activity. Proc National Acad Sci USA, 1998. 95(2): p. 669-674. 
 
33. Tassew, N.G.; Charish, J.; Chestopalova, L.; Monnier, P.P. Sustained in vivo 
inhibition of protein domains using single-chain Fv recombinant antibodies and 
its application to dissect rgma activity on axonal outgrowth. J Neurosci, 2009. 
29(4): p. 1126–1131. 
 
34. Di Lullo, E.; Haton, C.; Le Poupon, C.; Volovitch, M.; Joliot, A.; Thomas, J.L.; 
Prochiantz, A. Paracrine Pax6 activity regulates oligodendrocyte precursor cell 
 76 
 
migration in the chick embryonic neural tube. Development, 2011. 138(22): p. 
4991–5001. 
 
35. Kobayashi, N.; Odaka, K.; Uehara, T.; Imanaka-Yoshida, K.; Kato, Y.; Oyama, 
H.; Tadokoro, H.; Akizawa, H.; Tanada, S.; Hiroe, M.; et al. Toward in vivo 
imaging of heart disease using a radiolabeled single-chain Fv fragment targeting 
tenascin-C. Anal Chem, 2011. 83(23): p. 9123–9130. 
 
36. Bard, F.; Cannon, C.; Barbour, R.; Burke, R.L.; Games, D.; Grajeda, H.; Guido, 
T.; Hu, K.; Huang, J.; Johnson-Wood, K.; et al. Peripherally administered 
antibodies against amyloid beta-peptide enter the central nervous system and 
reduce pathology in a mouse model of Alzheimer disease. Nat Med, 2000. 6(8): 
p. 916-919. 
 
37. Curigliano, G.; Spitaleri, G.; Dettori, M.; Locatelli, M.; Scarano, E.; Goldhirsch, 
A. Vaccine immunotherapy in breast cancer treatment: Promising, but still early. 
Expert Rev Anticancer Ther, 2007. 7(9): p. 1225–1241. 
 
38. Deckert, P.M. Current constructs and targets in clinical development for 
antibody-based cancer therapy. Curr Drug Targets, 2009. 10(2): p. 158–175. 
 
39. Liu, W.; Onda, M.; Lee, B.; Kreitman, R.J.; Hassan, R.; Xiang, L.; Pastan, I. 
Recombinant immunotoxin engineered for low immunogenicity and antigenicity 
by identifying and silencing human B-cell epitopes. Proc Natl Acad Sci USA, 
2012. 109(29): p. 11782–11787. 
 
40. Carvalho, A.P.; Meireles, L.A.; Malcata, F.X. Microalgal reactors: a review of 
enclosed system designs and performances. Biotechnol Prog, 2006. 22(6): p. 
1490-1506. 
 
41. Perez-Garcia, O.; Escalante, F. M. E.; de-Bashan, L. E.; Bashan, Y. 
Heterotrophic cultures of microalgae: Metabolism and potential products. Water 
Res , 2011. 45(1): p. 11-36. 
 
42. Oswald, W.J. Micro-algae and waste-water treatment, in Microalgal 
Biotechnology, M.A.B. Borowitzka, L.J., Editor. 1992, Cambridge University 
Press: Cambridge. p. 305-328. 
 
43. Borowitzka, M.A. Commercial production of microalgae: ponds, tanks, and 
fermenters. Progress in Industrial Microbiology, 1999. 35(1-3): p. 313–321. 
 
44. Walker, T.; Purton, S.; Becker, D.; Collet, C. Microalgae as bioreactors. Plant 
Cell Rep, 2005. 24(11): p. 629-641. 
 
 77 
 
45. Chen, F. High cell density culture of microalgae in heterotrophic growth. Trends 
Biotechnol, 1996. 14(11): p. 421-426. 
 
46. Lee, K.; Lee, C.G. Effect of light/dark cycles on wastewater treatment by 
microalgae. Biotechnol Bioprocess Eng, 2001. 6(3): p. 194-199. 
 
47. Yang, C.; Hua, Q.; Shimizu, K. Energetics and carbon metabolism during growth 
of microalgal cells under photoautotrophic, mixotrophic and cyclic light-
autotrophic/dark-heterotrophic conditions. Biochem Eng J, 2000. 6: p. 87-102. 
 
48. Hong, S.J.; Lee, C.G. Evaluation of central metabolism based on a genomic 
database of Synechocystis PCC6803. Biotechnol Bioprocess Eng, 2007. 12(2): p. 
165-173. 
 
49. Kaplan, D.; Richmond, A.E.; Dubinsky, Z.; Aaronson, S. Algal nutrition, in 
Handbook for Microalgal Mass Culture, A. Richmond, Editor. 1986, CRC Press: 
Boca Raton, FL., USA. 
 
50. Boyle, N.; Morgan, J. Flux balance analysis of primary metabolism in 
Chlamydomonas reinhardtii. BMC Syst Biol, 2009. 3(4). 
 
51. Rebeille, F.; Gans, P. Interaction between chloroplasts and mitochondria in 
microalgae. Plant Physiol, 1988. 88(4): p. 973-975. 
 
52. Coragliotti, A.; Beligni, M.; Franklin, S.; Mayfield, S.P. Molecular factors 
affecting the accumulation of recombinant proteins in the Chlamydomonas 
reinhardtii chloroplast. Mol Biotechnol, 2011. 48(1): p. 60-75. 
 
53. Danon, A.; Mayfield, S.P. Light regulated translational activators: identification 
of chloroplast gene specific mRNA binding proteins. The EMBO Journal, 1991. 
10(13): p. 3993-4001. 
 
54. Blowers, A.D.; Bogorad, L.; Shark, K.B.; Sanford, J.C. Studies on 
Chlamydomonas chloroplast transformation: foreign DNA can be stably 
maintained in the chromosome. Plant Cell, 1989. 1(1): p. 123-132. 
 
55. Blowers, A.D.; Ellmore, G.S.; Klein, U.; Bogorad, L. Transcriptional analysis of 
endogenous and foreign genes in chloroplast transformants of Chlamydomonas. 
Plant Cell, 1990. 2(11): p. 1059-1070. 
 
56. Ishikura, K.; Takaoka, Y.; Kato, K.; Sekine, M.; Yoshida, K.; Shinmyo, A. 
Expression of a foreign gene in Chlamydomonas reinhardtii chloroplast. J Biosci 
Bioeng, 1999. 87(3): p. 307-314. 
 
 78 
 
57. Danon, A.; Mayfield, S.P. ADP-dependent phosphorylation regulates RNA-
binding in vitro: implications in light-modulated translation. The EMBO Journal, 
1994. 13(9): p. 2227-2235. 
 
58. Pruvost, J. Cultivation of Algae in Photobioreactors for Biodiesel Production, in 
Biofuels: Alternative Feedstocks and Conversion Processes, A. Pandey, Editor. 
2011, Elsevier Inc.: USA. p. 439-466. 
 
59. Danon, A.; Mayfield, S.P. Light-Regulated Translation of Chloroplast Messenger 
RNAs Through Redox Potential. Science, 1994. 266(5191): p. 1717-1719. 
 
60. Scopes, R.C. Making an extract, in Protein Purification: Principles and Practice, 
R.C. Garber, Editor. 1994, Springer Science & Business Media. 
 
61. Wilken, L.R.; Nikolov, Z.N. Recovery and purification of plant-made 
recombinant proteins. Biotechnology Advances, 2012. 30(2): p. 419–433. 
 
62. Schwede, S.; Kowalczyk, A.; Gerber, M.; Span, R. Influence of different cell 
disruption techniques on mono digestion of algal biomass in World Renewable 
Energy Congress. 2011: Linkoping, Sweden. 
 
63. Woodard, S. L.; Wilken, L.R.; Barros, G.O.; White, S.G.; Nikolov, Z.L. 
Evaluation of monoclonal antibody and phenolic extraction from transgenic 
Lemna for purification process development. Biotechnol Bioeng, 2009. 104(3): p. 
562-71. 
 
64. Hassan, S.; Van Dolleweerd, C.J.; Ioakeimidis, F.; Keshavarz-Moore, E.;  K.-C. 
Ma, J. Considerations for extraction of monoclonal antibodies targeted to 
different subcellular compartments in transgenic tobacco plants. Plant Biotechnol 
J, 2008. 6(7): p. 733-748. 
 
65. Wilken, L.R.; Nikolov, Z.L. Factors influencing recombinant human lysozyme 
extraction and cation exchange adsorption. Biotechnol Progr, 2006. 22(3): p. 
745–752. 
 
66. Zhang, D.; Nandi, S.; Bryan, P.; Pettit, S.; Nguyen, D.; Santos, M.A.; Huang, N. 
Expression, purification, and characterization of recombinant human transferrin 
from rice (Oryza sativa L.). Protein Expres Purif, 2010. 74(1): p. 69–79. 
 
67. Azzoni, A.R.; Farinas, C.S.; Miranda, E.A. Transgenic corn seed for recombinant 
protein production: relevant aspects on the aqueous extraction of native 
components. J Sci Food Agric 2005. 85(4): p. 609-614. 
 
 79 
 
68. Farinas, C.S.; Leite, A.; Miranda, E.A. Aqueous extraction of recombinant 
human proinsulin from transgenic maize endosperm. Biotechnol Prog, 2005. 
21(1): p. 1466-1471. 
 
69. Barros, G.O.; Woodard, S.L.; Nikolov, Z.L. Phenolics removal from transgenic 
Lemna minor extracts expressing mAb and impact on mAb production cost. 
Biotechnol Progr, 2011. 27(2): p. 410-418. 
 
70. Tran, M.; Zhou, B.; Pettersson, P.L.; Gonzalez, M.J.; Mayfield, S.P. Synthesis 
and assembly of a full-length human monoclonal antibody in algal chloroplasts. 
Biotechnol. Bioeng., 2009. 104(4): p. 663-673. 
 
71. Danielle, H.; Singh, N.D.; Mason, H.; Streatfield, S.J. Plant-made vaccine 
antigens and biopharmaceuticals. Trends in Plant Science, 2009. 14(12): p. 669-
679. 
 
72. Scopes, R.K. Separation by Precipitation, in Protein Purification: Principles and 
Practice, R.C. Garber, Editor. 1994, Springer Science & Business Media. 
 
73. Kumar, A.; Galave, I.Y.; Mattiasson, B. Precipitation of proteins: Nonspecific 
and Specific, in Isolation and Purification of Proteins, R.M. Hatti-Kaul, B., 
Editor. 2003, Marcel Dekker, Inc: New York. 
 
74. Lai, H.; Engle, M.; Fuchs, A.; Keller, T.; Johnson, S.; Gorlatov, S.; Diamond, 
M.S.; Chen, Q. Monoclonal antibody produced in plants efficiently treats West 
Nile virus infection in mice. Proc Natl Acad Sci U S A, 2010. 107(6): p. 2419-
2424. 
 
75. Peckham, G.D.; Bugos, R.C.; Su, W.W. Purification of GFP fusion proteins from 
transgenic plant cell cultures. Protein Expres Purif, 2006. 49(2): p. 183-189. 
 
76. Huang, L.F.; Liu, Y.K.; Lu, C.A.; Hsieh, S.L.; Yu, S.M. Production of human 
serum albumin by sugar starvation induced promoter and rice cell culture. 
Transgenic Res, 2005. 14(5): p. 569-581. 
 
77. Garger, S.J.; Holtz, B.; McCulloch, M.J.; Turpen, T.H., Process for isolating and 
purifying viruses, soluble proteins and peptides from plant sources. 2000, 
Biosource Technologies, Inc.: United States. 
 
78. Wilken, L.R.; Nikolov, Z.L. Evaluation of alternatives for human lysozyme 
purification from transgenic rice: impact of phytic acid and buffer. Biotechnol 
Progr, 2010. 26(5): p. 1303–1311. 
 
 80 
 
79. Vézina, L.P.; Faye, L.; Lerouge, P.; D'Aoust, M.A.; Marquet-Blouin, E.; Burel, 
C., Lavoie, P.O.; Bardor, M.; Gomord, V. Transient co-expression for fast and 
high-yield production of antibodies with human-like N-glycans in plants. Plant 
Biotechnol 2009. 7(5): p. 442–455. 
 
80. Liu, H.F.; Ma, J.; Winter, C.; Bayer, R. Recovery and purification process 
development for monoclonal antibody production MAbs, 2010. 2(5): p. 480–499. 
 
81. Holler, C.; Vaughan, D.; Zhang, C. Polyethyleneimine precipitation versus anion 
exchange chromatography in fractionating recombinant-glucuronidase from 
transgenic tobacco extract. Journal of Chromatography A, 2007. 1142(1): p. 98–
105. 
 
82. Hughes, J.; Ramsden, D.K.; Symes, K.C. The flocculation of bacteria using 
cationic synthetic flocculants and chitosan. Biotechnol Tech, 1990. 4(1): p. 55–
60. 
 
83. Persson, I.; Lindman, B. Flocculation of Cell Debris for Improved Separation by 
Centrifugation., in Flocculation in biotechnology and separation systems. 1987, 
Elsevier Science: Amsterdam. p. 457–466. 
 
84. Hashimoto, M.; Yamamoto, T.; Kawachi,T.; Kuwashima, J.; Kitaoka, H. Low 
molecular weight chitosans for the removal of nucleic acids and/or endotoxins 
from liquid samples on a small or large scale. 1987. 
 
85. Novikov, V.Y.; Mukhin, V.A. Defatting and clarification of protein hydrolysates 
by using chitosan solutions. Appl Biochem Microbiol, 2001. 37(6): p. 629–634. 
 
86. Agerkvist, I.; Eriksson, L. Selective flocculation with chitosan in E. coli 
disintegrates: effects of ionic strength and multivalent metal ions. Dispers Sci 
Technol, 1993. 14(9): p. 269–293. 
 
87. Weir, S.; Ramsden, D.K.; Hughes, J.; LeThomas, F. The flocculation of yeast 
with chitosan in complex fermentation media: the effect of biomass 
concentration and mode of flocculant addition. Biotechnol Tech, 1993. 7(3): p. 
199–204. 
 
88. Garzon-Sanabria, A.J.; Davis, T.; Nikolov, Z.L. Harvesting Nannochloris 
oculata by inorganic electrolyte flocculation: Effect of initial cell density, ionic 
strength, coagulant dosage, and media pH. Bioresource Technology, 2012. 118: 
p. 418–424. 
 
89. Riske, F.; Schroeder, J.; Belliveau, J.; Kangb, X.; Kutzko, J.; Menona, M.K. The 
use of chitosan as a flocculant in mammalian cell culture dramatically improves 
 81 
 
clarification throughput without adversely impacting monoclonal antibody 
recovery. Journal of Biotechnology, 2007. 128(4): p. 813–823. 
 
90. Lauersen, K.J.; Berger, H.; Mussgnug, J.H.; Kruse, O. Efficient recombinant 
protein production and secretion from nuclear transgenes in Chlamydomonas 
reinhardtii. Journal of Biotechnology, 2013. 167(2): p. 101–110. 
 
91. Kaslow, D.C.; Shiloach, J. Production, purification and immunogenicity of a 
malaria transmission-blocking vaccine candidate: TBV25H expressed in yeast 
and purified using nickel-NTA agarose. Nat Biotech, 1994. 12(5): p. 494-499. 
 
92. Herman, C.A.; Im, C.S.; Beale, S.I. Light-regulated expression of the gsa gene 
encoding the chlorophyll biosynthetic enzyme glutamate 1-semialdehyde 
aminotransferase in carotenoid-deficient Chlamydomonas reinhardtii cells. Plant 
Mol Biol, 1999. 39(2): p. 289-297. 
 
93. Bohne, F.; Linden, H. Regulation of carotenoid biosynthesis genes in response to 
light in Chlamydomonas reinhardtii. Biochim Biophys Acta, 2002. 1579(1): p. 
26-34. 
 
94. Barneche, F.; Winter, V.; Crevecoeur, M.; Rochaix J.D. ATAB2 is a novel factor 
in the signalling pathway of light-controlled synthesis of photosystem proteins. 
EMBO J, 2006. 25(24): p. 5907-5918. 
 
95. Franklin, S.; Ngo, B.; Efuet, E.; Mayfield, S.P. Development of a GFP reporter 
gene for Chlamydomonas reinhardtii chloroplast. Plant J, 2002. 30(6): p. 733–
744. 
 
96. Gregory, J.A.; Topol, A.B.; Doerner, D.Z.; Mayfield, S.P. Alga-Produced 
Cholera Toxin-Pfs25 Fusion Proteins as Oral Vaccines. Appl Environ Microbiol, 
2013. 79(13): p. 3917-3925. 
 
97. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram 
quantities of protein utilizing the principle of protein-dye binding. Anal 
Biochem, 1976. 72: p. 248-254. 
 
98. Malnoë, P.; Mayfield, S.P.; Rochaix, J.D. Comparative analysis of the biogenesis 
of photosystem II in the wild-type and Y-1 mutant of Chlamydomonas 
reinhardtii. J Cell Biol, 1988. 106(3): p. 609-616. 
 
99. Griffiths, M.J.; Garcin, C.; van Hille, R.P.; Harrison, S.T.L. Interference by 
pigment in the estimation of microalgal biomass concentration by optical density. 
J Microbiol Methods, 2011. 85(2): p. 119-123. 
 
 82 
 
100. Villaverde, A.; Carrió, M.M. Protein aggregation in recombinant bacteria: 
biological role of inclusion bodies. Biotechnology Letters, 2003. 25(17): p. 1385-
1395. 
 
101. Miles, A.P.; Zhang, Y.; Saul, A.; Stowers, A.W. Large-Scale Purification and 
Characterization of Malaria Vaccine Candidate Antigen Pvs25H for Use in 
Clinical Trials. Protein Expression and Purification, 2002. 25(1): p. 87–96. 
 
102. Miyata, T.; Harakuni, T.; Tsuboi, T.; Sattabongkot, J.; Kohama, H.; Tachibana, 
M.; Matsuzaki, G.; Torii, M.; Arakawa, A. Plasmodium vivax Ookinete Surface 
Protein Pvs25 Linked to Cholera Toxin B Subunit Induces Potent Transmission-
Blocking Immunity byIntranasal as Well as Subcutaneous Immunization. 
Infection and Immunity 2010. 78(9): p. 3773–3782. 
 
103. Roush, D.J.; Lu, Y. Advances in Primary Recovery: Centrifugation and 
Membrane Technology. Biotechnol Prog, 2008. 24(3): p. 488-495. 
 
104. Nikolov, Z.L.; Regan, J.T.; Dickey, L.F.; Woodard, S.L. Purification of 
antibodies from transgenic plants, in Process Scale Purification of Antibodies, U. 
Gottschalk, Editor. 2009, John Wiley & Sons Inc: Hoboken, NJ. p. 387-406. 
 
105. Woodard, S.L.; Wilken, L.R.; Barros, G.O.F.; White S.G.; Nikolov, Z.L. 
Evaluation of monoclonal antibody and phenolic extraction from transgenic 
Lemna for purification process development. Biotechnol Bioeng, 2009. 104(3): p. 
562–571. 
 
106. Platis, D.; Drossard, J.; Fischer, R.; Ma, J.K.C.; Labrou, N.E. New downstream 
processing strategy for the purification of monoclonal antibodies from transgenic 
tobacco plants. J Chromatogr A, 2008. 1211(1-2): p. 80-89. 
 
107. Ross, K.C.; Zhang, C. Separation of recombinant β-glucuronidase from 
transgenic tobacco by aqueous two-phase extraction. Biochem Eng J, 2010. 
49(3): p. 343–350. 
 
108. Holler, C.; Vaughan, D.; Zhang, C. Polyethyleneimine precipitation versus anion 
exchange chromatography in fractionating recombinant-glucuronidase from 
transgenic tobacco extract. J Chrom A, 2007. 1142(1): p. 98-105. 
 
109. Divakaran, R.; Pillai, V.N.S. Flocculation of algae using chitosan. Journal of 
Applied Phycology, 2002. 14: p. 419–422. 
 
110. Garzon-Sanabria, A.J.; Ramirez-Caballero, S.S.; Moss, F.E.; Nikolov, Z.L. 
Effect of algogenic organic matter (AOM) and sodium chloride on 
 83 
 
Nannochloropsis salina flocculation efficiency. Bioresource Technology, 2013. 
143: p. 231–237. 
 
111. Munjal, N.; Garzon-Sanabria, A.J.; Quinones, K.W.; Gregory, J.; Nikolov, Z.L. 
Light-Induced Production of An Antibody Fragment and Malaria Vaccine 
Antigen from Chlamydomonas reinhardtii. Processes, 2014. 2: p. 625-638. 
 
 
 
 
 
 84 
 
APPENDIX 
 
 
Appendix 1. Effect of resuspension on accumulation of recombinant proteins 
 
Table A1.1. Effect of resuspension on the growth of C. reinhardtii and accumulation of 
recombinant protein αCD22 scFv in the chloroplast. 
Cultivation Biomass (g) % TSP (µg/µg) 
Wet biomass 
conc. (µg/g) 
Culture Conc. 
of R-protein 
αCD22 scFv 
(µg/L) 
With 
resuspension 
4 0.12 ± 0.03 35.1 ± 5.8 140.5 ± 23 
Without 
resuspension 
2 0.13 ± 0.00 26.3 ± 5.4 52.9 ± 11 
 
Table A1.2. Effect of resuspension on the growth of C. reinhardtii and accumulation of 
recombinant protein αCD22PE40 (MT 47). R: Resuspended; NR: Non resuspended. 
Samples 
Biomass (g) 
Total 
Soluble 
Protein 
(µg/ml) 
µg of 
MT47 
recovered 
in E2-E3  
R-protein/TSP 
(%) 
R-
protein/wet 
biomass (%) 
R NR R NR R NR R NR R NR 
Batch 1 3.5 2.3 5973 3243 45.3 11 0.04 0.03 13 4.8 
Batch 2 3.9 2.4 3810 3561 14.2 7.2 0.018 0.016 3.7 3 
Batch 3 3.7 
 
5459 
 
20.7 
 
0.020 
 
5.6  
Batch 4 3.45 
 
4303 
 
16.5 
 
0.022 
 
4.8  
Batch 5 3.6 
 
4663 
 
22.5 
 
0.027 
 
6.25  
Scale up 
36 h light 
2.9 g 
purification 
5865 
E2-E3: 
41.87 
0.06 
 
14.5 
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Figure A1.1. Comparison (resuspension vs. non resuspension) of Western blot analysis 
(using anti-FLAG-AP conjugated antibody) of C. reinhardtii containing αCD22PE40 
(MT 47) (64kDa) purified from cell-free extract. Lane 1: marker; Lane 2: clarified initial 
extract (resuspended); Lane 3: supernatant after 2 h of binding with anti-FLAG resin 
(resuspended); Lanes 4 to 6: pH 3.5 eluted fractions (resuspended); Lane 7: clarified 
initial extract (non resuspended); Lane 8: supernatant after 2 h of binding with anti-
FLAG resin (non resuspended); Lanes 9 to 10: pH 3.5 eluted fractions (non 
resuspended). Significant degradation was observed. 
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Appendix 2. Effect of pretreatment on turbidity and filterability of algae extract 
 
Table A2.1. Effect of pretreatment and stage of pretreatment on the turbidity of algae 
extract and filtration load capacity (0.45 µm). 
 
Stage of Primary 
Recovery 
Pre-filter 
OD750 
Post-filter 
OD750 
Load 
Capacity (%) 
No Pretreatment Filtered Extract 0.49 ± 0.08 0.23 ± 0.04 100 
Ammonium 
sulfate (1M) 
precipitation 
Cell free extract 0.15 ± 0.03 0.05 ± 0.04 244 ± 204 
Cell lysate 0.17 ± 0.03 0.07 ± 0.06 165.5 ± 48.7 
Acidic 
precipitation at 
pH=4.5 
Cell free extract 0.27 ± 0.11 0.16 ± 0.04 177 ± 89.1 
Cell lysate 0.22 ± 0.08 0.14 ± 0.03 137 ± 41 
Chitosan 
precipitation 
Cell lysate 0.04 ± 0.00 0.02 ± 0.01 263 ± 1.86  
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Appendix 3. Purification of αCD22 scFv by Capto L affinity chromatography 
 
Table A3.1. Batch purification of αCD22 scFv (purified by anti-FLAG affinity 
chromatography) on Capto L resin. 
αCD22 scFv (FLAG purified) αCD22 scFv (Capto L purified) Yield 
56.1 µg 23.9 µg 43% 
 
 
Figure A3.1. Western blot analysis (using anti-FLAG-AP conjugated antibody) of C. 
reinhardtii αCD22 scFv purified from cell-free extract by Capto L resin affinity 
chromatography. Lane 1: marker; Lane 2: αCD22 scFv (MT44) purified by anti-FLAG 
resin; Lane 3: supernatant after 2 h of binding with Capto L resin; Lanes 4 to 6: washes 
before elution; Lanes 7 to 10: pH 3.5 eluted fractions. 
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Table A3.2. Comparison of batch purification of αCD22 scFv by anti-FLAG and Capto 
L affinity chromatography. 
αCD22 scFv (FLAG purified) αCD22 scFv (Capto L purified) Yield by Capto L 
25.73 µg/g biomass 13.9 µg/g biomass 54.4% 
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Figure A3.2. Comparison of Western blot analysis (using anti-FLAG-AP conjugated 
antibody) of C. reinhardtii αCD22 scFv purified from cell-free extract by Capto L resin 
(a) and anti-FLAG resin (b). Lane 1: marker; Lane 2: clarified initial extarct; Lane 3: 
supernatant after 2 h of binding with Capto L resin and anti-FLAG; Lanes 4 to 7: washes 
before elution (Capto L resin); Lanes 8 to 10: pH 3.5 eluted fractions (Capto L resin); 
Lanes 4 to 8: pH 3.5 eluted fractions (anti-FLAG resin). 
(a) 
(b) 
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Figure A3.3. Anti-FLAG purified αCD22 scFv loaded on Capto L resin affinity column. 
UV280: Two peaks at flow through and one peak at elution was observed. 
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Figure A3.4. Western blot analysis (using anti-FLAG-AP conjugated antibody) of C. 
reinhardtii containing αCD22 scFv purified from Capto L Affinity column 
(chromatogram in Figure A3.3); Lane 1: marker; Lane 2 to 4: flow through fractions A3-
A5; Lane 5 to 8: elution fractions A10-A14. There was significant loss of αCD22 scFv in 
the flow through. Hence Capto L resin affinity chromatography was inefficient for the 
target protein. 
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Figure A3.5. Pretreated algae lysate (ammonium sulfate precipitation vs. acidic 
precipitation) loaded on Capto L resin affinity column. UV280: Blue eluate peak is of 
ammonium sulfate precipitation; Yellow eluate peak is of no pretreatment; Green eluate 
peak is of acidic precipitation. 
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Figure A3.6. Comparison (No pretreatment vs. Acidic precipitation on cell lysate) of 
Western blot analysis (using anti-FLAG-AP conjugated antibody) of C. reinhardtii 
containing αCD22 scFv purified by Capto L Affinity column (chromatogram in Figure 
A3.5); (a) No pretreatment; Lane 1: marker; Lane 2 to 7: flow through fractions; Lane 8 
to 10: elution fractions. (b) Acidic precipitation on cell lysate; Lane 1: marker; Lane 2 to 
7: flow through fractions; Lane 8, 9: elution fractions. There was significant loss of 
αCD22 scFv in the flow through. Hence Capto L resin affinity chromatography was 
inefficient for the target protein. 
